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Abstract 
There are more than 2 million end stage renal disease (ESRD) patients in the world. 
ESRD is becoming more manageable with the advent of competent therapies such as 
peritoneal dialysis (PD) and hemodialysis (HD). While recent evidence suggests that 
switching from PD to HD may preserve residual renal function longer than either PD or 
HD alone as an alternative approach, little is known about the optimal timing and the 
long-term efficacy of switching dialysis modes. The purpose of this quantitative 
retrospective study, based on the bio-psychosocial model, was to investigate the optimal 
timing and determinants of the effectiveness of switching dialysis modes from PD to HD. 
Data were extracted from a national database of ESRD dialysis patients. The Kaplan-
Meier survival curve and the log-rank test were used to determine the effect of optimal 
dialysis time for switching from PD to HD on ESRD patient’s survival and mortality. The 
results showed the optimal duration for switching dialysis modalities was 9 months where 
patients had a 90% survival rate after switching. ESRD patients taking more than 24 
months to switch modes had the highest loss of renal function. Also, patients between 40 
and 80 years of age were at a significantly higher hazard of renal function loss than 
patients younger than 40 years of age. It was concluded that timely switching of dialysis 
mode from PD to HD increases survival in ESRD patients. Younger patients have better 
survival rates in peritoneal dialysis modality than older patients. Moreover, females 
switching from PD to HD have better survival rates than males. The positive social 
change implications of this study may help raise awareness to the importance of optimal 
timing when switching dialysis modalities for improved survival and quality of life.
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Chapter 1: Introduction to the Study 
Introduction 
End stage renal disease (ESRD) is the permanent failure of the kidneys either 
slowly over time or suddenly (Santoro et al., 2013). The sole treatment of ESRD is renal 
replacement therapy (RRT) which includes transplantation, peritoneal dialysis (PD) or 
hemodialysis (HD) (Stephen et al., 2014). Most ESRD patients prefer having a kidney 
transplant but this is greatly hindered by an insufficient supply of  donor organs (Stephen 
et al., 2014). The National Kidney Foundation (2016) estimated that the prevalence of 
ESRD in the world is on rise with USA having 660, 000 cases in 2015 from 173,000 
cases in 2013. The United States Renal System (2013) made a global comparison of 
ESRD prevalence. In the survey, more than 70% of the sampled countries reported to 
have at least 80% of ESRD patients on HD while 17% were on PD and the 3% on other 
treatment modes (The United States Renal System, 2013). 
This study used data from National Dialysis Center that has the relevant 
information needed in the study. The data from National Dialysis Center (2011) database 
showed that the population of people living with ESRD had increased from 2 million in 
2010 to 2.1 million in 2011 and will continue to increase steadily with a 6% to 7% yearly 
increase projected in the future with more than 75% of the patients undergoing dialysis.  
Technique failure has been defined in several ways in the literature. It is the 
discontinuation of dialysis mode (Quinn, Ravani, & Hochman, 2010). Technique failure 
is any change from PD to HD for at least 30 days (Shen, Mitani, Saxena, Goldstein, & 
Winkelmayer, 2012) or a permanent change to HD (Descœudres et al., 2008). These 
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varied definitions can lead to differences in the reported risk of technique failure as well 
as inconsistencies between countries or programs (Quinn et al., 2010). In this study, 
technique failure is defined as switching from PD to HD within a period of 6 months.  
There are factors playing a role in the success or failure of ESRD treatment such 
as socio-demographic factors and financial and social support, which should be taken into 
consideration in maintaining PD (Shen et al., 2012). In a similar study, Weinhandl et al. 
(2010) found that diabetes, cardiovascular disease, and age, all play a role in survival 
rates and determination of the technique to be adopted.  However, Weinhandl et al. only 
explored HD and PD. 
Switching of dialysis modes can increase success rates when treating ESRD 
patients. Suzuki, Hoshi, Inoue, Kikuta, and Takane, (2013) sought to establish the effects 
of patient transfer from either mode of dialysis or a combination of both HD and PD. 
Patients were monitored monthly during the study. At each, visit complete blood count 
and electrolyte concentrations were measured. The findings of the study indicated that the 
sequence of beginning treatment with PD followed by a switch to HD is a valuable way 
of treating ESRD patients (Suzuki et al., 2012). The researchers suggested that patients 
who need dialysis therapy should consider the new dialysis approach of PD first and 
transfer to home HD (Suzuki et al., 2012). Similarly, Stanley (2010) and Shen et al. 
(2012) explored the efficacies of PD and HD and concluded that a well-timed transfer 
from PD to HD may enhance the survival of a patient. The researchers also added that 
technique failure is associated with socio-demographic factors (Stanley, 2010; Shen et al., 
2012). In their study, Shen et al. (2012) used a nationally representative sample of 1,587 
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US patients who had begun dialysis on PD. In this study, I utilized a larger national 
database of over 100,000 dialysis patients to evaluate the effectiveness of PD and 
switching from PD to HD. In addition, I will also seek to establish the determinants 
associated with the occurrence of dialysis technique failure. 
Background of the Study 
During dialysis, there is a possibility of loss in renal function and after loss of 
renal function PD may lead to a worse outcome than HD, whereas, a timely transfer may 
increase the long-term survival (Stanley, 2010). Pajek et al. (2014) examined if the timing 
of the switch from PD to HD affected mortality rate of patients with renal disease. They 
concluded that the timing of the switch had no significant effect on the mortality rate of 
patients. However, the limitation of their study was that they could only examine the 
effect of the timing of the switch for 4years as a result of patient mortality.    
Theofilou (2012) noted that the advantages associated with PD include preserving 
RRF (Residual Renal Function) and long, gradual, progressive ultrafiltration. The current 
study used GFR measures provided at the National Dialysis Center database for all the 
patients because GFR are routinely monitored to determine the renal function of patients. 
Data for survival times was also collected from the National Dialysis Center database. 
RRF is independently associated with endothelial dysfunction in ESRD patients on PD, 
suggesting that RRF may contribute to endothelial protection in these patients (Han et al., 
2012). The GFR at the medical database are already standards as per the guidelines 
provided by the National Kidney Foundation. Medical conditions such as diabetes and 
cardiovascular diseases are significant risk factors that contribute to the deaths of ESRD 
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patients (Pajek et al., 2014; Sud, Tangri, Pintilie, Levey, & Naimark, 2014), whereas 
demographic factors such as age and gender and presence of other health conditions play 
a role in the success of dialysis (Theofilou, 2012; Weinhandl et al., 2010). I included 
patients who began on PD first and then switched to HD in different time periods to 
examine if the timing of the switch had any impact in renal function and survival times of 
ESRD patients (Pajek et al., 2014).  
There should be increased focus to identify patients at higher risk for peritonitis 
besides evaluating the care processes and implementation of preventive strategies for 
patients switching from PD to HD (Pulliam et al., 2014). Pajek et al. (2014) found that 
peritonitis is a cause of technique failure followed by ultrafiltration failure and that when 
the successful switch to HD, which was surviving at least 60 days after technique failure, 
and timing were evaluated, no adverse effect on survival in adjusted analysis was 
revealed. 
The approach of starting PD and then switching to HD was also proposed by 
Suzuki et al. (2013) who attributed the advantages to improved preservation of RRF, 
longer survival times, and a lower occurrence of hospitalizations. Suzuki et al. (2013) 
noted that the outcomes of a dialysis approach should be evaluated against the specified 
standards provided by the National Kidney Foundation Kidney Disease Outcomes 
Quality Initiative (NKF KDOQI). The KDOQI outlines what should be carried out by 
medical practitioners, caregivers, and patients themselves to ensure that those with ESRD 
lead the best possible quality of life as they undergo treatment (Inker et al., 2014). The 
NKF KDOQI provides definition and stages of ESRD, evaluation, and treatment, 
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individuals at increased risk of ESRD. In addition it also offers evaluation of laboratory 
measurements for ESRD and estimation of GFR.  
Problem Statement 
ESRD is an economic, social, as well as medical burden. With the advent of PD 
and HD therapies, ESRD is becoming manageable (Finnegan-John & Thomas, 2012). 
Whereas both PD and HD have shown great promise (Mehrotra, Chiu, Kalantar-Zadeh, 
Bargman, & Vonesh, 2011; Yeates et al., 2012), both techniques are prone to loss of RRF 
over time, which is also impacted by co-morbidities particularly for patients on PD 
(Hoshi et al., 2006; Weinhandl et al., 2010). Recent studies by Stanley (2010), Shen et al. 
(2012), and Suzuki et al. (2012) have shown that switching from PD to HD can improve 
the renal functions of patients, but whether this translates to longer survival times has not 
yet been demonstrated. There is little data in the United States addressing the outcomes 
and factors associated with switching modalities from PD to HD (Jaar et al., 2009). A PD 
First approach not only has benefits for patients but also physicians, and healthcare 
systems (Ghaffari et al., 2013). However, the researchers did not conduct an empirical 
study; a gap which will be filled by this study by using data available in a national 
database. Pajek et al.’s (2014) findings that switching from PD to HD can improve the 
survival times of patients was inconclusive, partly because of the small sample size used. 
The study by Jaar et al. (2009) only used a sample size of 262 patients and Pulliam et al. 
(2014) used a sample size of 1,167 patients. In this study, the sample size limitations of 
previous studies were addressed by using a larger sample size to determine the optimal 
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time for switching from PD to HD and whether or not the timing influences the survival 
times of patients.  
This study utilized a sample of patient records from a national registry database of 
over 128,000 dialysis patients to examine the optimal dialysis time for switching from PD 
to HD on renal function and survival times for ESRD patients and the impact of patient 
demographic and comorbidity factors as possible modifiers.  
Purpose of the Study 
The purpose of this quantitative retrospective study was to examine whether the 
timing of the switch from PD to HD is more effective on maintaining renal function and 
survival times for ESRD patients than those on PD or HD alone. Although several studies 
have been conducted to examine the efficacy of PD and HD alone and switching from PD 
to HD, they have utilized small sample sizes which limit the generalizability of the 
findings (Creswell, 2003). Examples include studies by Suzuki et al. (2012) and Moriishi, 
Kawanishi, and Tsuchiya (2010) using data from the Australia and New Zealand dialysis 
and transplants registry involving 2,715 patients with ESRD treated with PD, HD, and 
switch to HD who used considerably smaller samples who were home based. The current 
study utilized a sample of patient records from a national registry database of over 
128,000 dialysis patients undergoing dialysis at National Dialysis Center, a dialysis 
specialized hospital dealing with hospital based patients, to examine if switching from 
PD to HD improves renal function and survival times. The researcher also explored the 
effect of independent and multivariate demographic (age and gender) and comorbidities 
(diabetes and cardiovascular (CVD)) determinants on the dependent variables.  
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Research Questions 
This study focused on examining whether the timing of the switch from PD to HD 
impacts renal function and survival times including if demographic factors such as age 
and gender, and comorbidities such as diabetes and cardiovascular disease, also impact 
both renal function and survival times for ESRD patients. The renal function was 
assessed using the GFR and the data for survival times was collected from the National 
Dialysis Center database. The Chi-square test of independence was utilized to show the 
link between cardiovascular disease, diabetes, and demographic factors (age and gender) 
and optimal dialysis time for switching from PD to HD. The study was guided by the 
following research questions: 
RQ1: Is the dialysis time for switching from PD to HD for ESRD Patients associated 
with improved renal function and survival times, when controlling for demographic and 
comorbidity patient factors? 
RQ2: Do comorbidities modify the dialysis time for switching from PD to HD for 
ESRD Patients associated with improved renal function and survival times, when 
controlling for demographic patient factors? 
RQ3: Do demographic patient factors modify the dialysis time for switching from PD 
to HD for ESRD Patients associated with improved renal function and survival times, 
when controlling for comorbidity patient factors? 
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Research Hypotheses 
Hypotheses 
H01: The timing of the switch from PD to HD does not impact renal function and 
survival times when controlling for demographic and patient factors. 
Ha1: The timing of the switch from PD to HD impacts renal function and survival 
times. 
H02: Comorbidities do not impact the dialysis time of switching from PD to HD when 
controlling for demographic patient factors. 
Ha2: Comorbidities impact the dialysis time of switching from PD to HD when 
controlling for demographic patient factors 
H03: Demographic factors do not impact the dialysis time of switching from PD to 
HD when controlling for comorbidity patient factors. 
Ha3: Demographic factors impact the dialysis time of switching from PD to HD when 
controlling for comorbidity patient factors? 
Theoretical Framework 
This study utilized the bio-psychosocial model. The model helps to explain the 
interplay between social, physical, and environmental factors (Janowski, 2009). In this 
study, the use of the bio-psychosocial model enabled me to study the interplay between 
social factors such as sex, age, and comorbidities of ESRD patients and the influence of 
these factors on the various modalities used in treatment. The model allowed me to study 
the interplay between the treatment modalities of HD, PD, the switching from PD to HD, 
and any changes in renal function and survival times of ESRD patients. 
9 
 
Social factors affecting the interplay between the treatment modalities of HD, PD, 
or the transition from PD to HD and renal function of ESRD patients in the methodology 
were examined through quantitative methods of research. These factors included sex, age, 
and comorbidities of ESRD patients. Determining the optimal time to switch from PD to 
HD helped to guide best practices for ESRD dialysis protocols, guide on the effectiveness 
of the dialysis technique, and improve the patient outcomes.  
Nature of the Study 
The study used a quantitative retrospective research design and used a sample of 
available cases in the database to allow for data collection process. A quantitative 
research method is the collection and manipulation of numerical data with an aim of 
meaningfully describing the phenomenon that the data represent (Creswell, 2009). I used 
case control in order to be consistent with the research questions and how the study was 
conceptualized, as it determined whether the timing of the switching from PD to HD 
significantly improved renal function and survival times for ESRD patients compared to 
either PD or HD alone.   
The study sought to evaluate if the timing of switching from PD to HD 
significantly improves renal function and survival times in ESRD patients. By using case 
control, I was able to compare changes in renal function from one group of patients 
(PD/HD with and without diabetes and cardiovascular diseases) with another group of 
patients who switched from PD to HD. Renal function was measured by use of the 
glomerular filtration rate (GFR). An estimated GFR (eGFR) calculated from serum 
creatinine (Scr) using the IDMS-traceable Modification of Diet in Renal Disease 
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(MDRD) formula GFR (mL/min/1.73 m2) = 175 x (Scr)-1.154 x (Age)-0.203 x (0.742 if 
female) x (1.212 if African American) (conventional units) (National Kidney Foundation, 
2014). It is worth noting that this IDMS-traceable MDRD study equation calculator is for 
use with Scr reported in mg/dL. The equation does not require weight because the results 
are reported normalized to 1.73 m2 body surface area, which is an accepted average adult 
surface area. The study used the calculated GFR measure stored in the National Dialysis 
Center database for all the patients which is a standardized measure per the guidelines 
provided by the National Kidney foundation (National Kidney Foundation, 2014). The 
RRF is calculated using 24-h urine collections by determining the mean of creatinine and 
urea clearance. The clearance rate is then normalized to a body surface area of 1.73 m2 
(Nongnuch, Assanatham, Panorchan, & Davenport, 2015). 
To analyze Research Question 1, the patients were grouped into clusters of the 
same timing for switchers switching from PD to HD, same gender, those with diabetes, 
same age, and cardiovascular diseases. I used a sample of the available data in the 
database of National Dialysis Center where the data was categorized into patients on PD, 
HD, and PD to HD and assessed whether the factors stated above had significant 
relationships or differences among themselves. The inclusion criteria of the sample was 
ESRD patients who are on PD, HD, and PD to HD, 20 years old and above, with 
comorbidities of diabetes and/or cardiovascular disease (CVD). The samples not 
matching these criteria were excluded from the study. The optimal dialysis time was 
determined by assessing the average number of months taken by ESRD patients to switch 
from PD to HD after having undergone dialysis for at least 6 months under PD dialysis 
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modality. To explore the effect of comorbidities on patient’s survival and renal function 
after undergoing switch from PD to HD, Cox-proportional hazards regressions were used. 
In the model, a positive regression coefficient for an explanatory variable implies that the 
hazard is higher, and thus the diagnosis worse (Zhao et al., 2014). Alternatively, a 
negative regression coefficient shows that there is a better diagnosis for patients with 
higher tenets of that variable. 
To assess the Research Questions 2 and 3, patients were grouped into clusters 
based on the timing of the switch from PD to HD. The Cox model (Schoenfeld residuals) 
was used in order to isolate the effect of timing of the switch from PD to HD on renal 
functioning (Pajek et al., 2014). This was achieved by having different strata with 
different baseline hazard functions that denote how the risk of event per time unit varies 
over time at baseline levels of covariate and the effect variables denoting how the hazard 
changes in response to explanatory covariates. Also, there was a group of patients with 
diabetes and without diabetes, and another group with cardiovascular diseases and 
without cardiovascular diseases for PD, HD alone, and those who started on PD then 
switched to HD after 6 months. The exact number of patients was not known until when 
the researcher started using the database but each group was assigned at least 1,200 
patients to ensure that the population sample size was appropriate and representative. I 
ensured the patients to be sampled were selected and spread across age groups below 20, 
20-30, 31-40, 41-50, 51-60, 61-70, and above 70. 
To address Research Questions 2 and 3, I analyzed whether the dialysis time of 
switching from PD to HD changed due to comorbidities such as cardiovascular disease 
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and diabetes and demographic factors such as age and gender. Multiple linear regressions 
and the biologically consistent Cochran Maentel Haenzsel test which is relevant and 
accurate with regard to the topic was used to assess the association between different 
factors and the switch from PD to HD across the different groups of patients (Schmidt & 
Kohlman, 2008). The multiple linear regression analysis was used to determine the 
impact of the independent variables of comorbidities such as cardiovascular disease and 
diabetes, and demographic factors such as age and gender to the dialysis time of 
switching from PD to HD. The effects of the different independent variables to the 
dependent variable were analyzed in a single regression model in order to compare the 
effects of the different independent variables. A level of significance value of 0.05 was 
used in order to determine the statistical significance of relationships in the regression 
analysis (Ziliak & McCloskey, 2013). A statistically significant impact by the 
independent variables to dependent variables was determined if the p-value of the 
regression was less than or equal to the level of significance value. If the p-value of the 
parameter estimate was significant at the 0.05 significance level, the null hypothesis was 
rejected, which implied that there would be a statistically significant impact by the 
independent variable to the dependent variable Then, the beta coefficient of the 
regression was investigated to determine how strongly the independent variable impacts 
with the dependent variable. A positive regression coefficient means a positive 
relationship indicating that the dependent variable increases as the independent variable 
increases (Chvostekova, 2013). A negative regression coefficient means a negative 
relationship indicating that the dependent variable decreases as the independent variable 
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increases (Chvostekova, 2013). The study based on the quantitave retrospective 
methodology focused on assessing the effectiveness of switching from PD to HD on 
patient’s survival and improving the residual renal function. The residual renal function 
was measured by glomerular filtration rate and assessed among group of patients in 
PD/HD and patients switching from PD to HD. Three research questions were developed 
to help evaluate the effectiveness of switching dialysis modalities. The Kaplan Meir tests, 
cox proportional hazard regression models and the Cochran Mantel Haesnzel models 
were used to test the hypotheses.   
Ethical Considerations 
The information retrieved from the data source, the Frenious Medical Care 
Facility database, was treated with high level of secrecy and confidentiality and was not 
divulged to any party or used for any other purpose apart for this research. The research 
was conducted in manner that upholds ethics of participants by ensuring their integrity, 
confidentiality, privacy, and seeking of consent (Check, Wolf, Dame, & Beskow, 2014).  
Definition of Terms 
A Peritoneal Equilibrium Test (PET). This is a test that was developed by 
Twardowski et al (1987) and is the commonly adopted test for determining peritoneal 
transport in PD patients. Glucose 2.27%/2.5% dialysate and a 4-h dwell are adopted 
during the test (citation). The test involves sampling and measuring protein, dialysate, 
serum, and low-molecular-weight solutes such as glucose, creatinine, and sodium among 
others (Struijk, 2008). 
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Encapsulating Peritoneal Sclerosis (EPS). This is a serious complication in PD 
patients and is characterized with symptoms such as obstructive ileus and varying levels 
of systemic inflammatory reaction, peritoneal thickening and encapsulation, cocooning, 
and obstruction of the intestines (Kawanishi & Moriishi, 2007). 
End Stage Renal Disease (ESRD). ESRD is a progressive permanent failure in 
renal function which affects’ the body’s capability to maintain fluid, metabolic and 
electrolyte balance resulting in retention of toxic wastes in the body (Santoro et al., 
2013). The most common reasons for failure are high blood pressure (hypertension) and 
diabetes which affect blood vessels over time and damage the kidney filters (American 
Nephrology Nurses Association, 2011). ESRD can also be caused by birth defects which 
affect blockages of urine flow, nephron infection, and trauma due to accidents (American 
Nephrology Nurses Association, 2011).  
Hemodialysis. This is one of the ESRD treating modes where toxins are removed 
and excess fluid through extracorporeal circulation of blood via artificial kidney or a 
dialyzer (Carolinas health care system, n.d). Toxins and other waste product pass through 
the membrane and are washed away but the filtering holes do not allow blood cells to 
pass due to their size (Carolinas health care system, n.d). The treatment is performed in 3 
to 4 hour sessions thrice weekly predominantly as center hemodialysis in hospitals or 
freestanding dialysis units (Carolinas health care system, n.d). In this case, the dialyzers 
are reprocessed and patient may re-use them several times (Carolinas health care system, 
n.d). If the patient and an assistant undergo training, the treatment may be performed at 
home (Carolinas health care system, n.d). 
15 
 
Peritoneal dialysis (PD). Peritoneal dialysis is a treatment for ESRD that uses the 
peritoneal membrane as an alternative to the dialyzer or artificial kidney (Carolinas health 
care system, n.d). The process requires the insertion of a catheter into the abdominal wall 
and recurring and installation and removal of sterile dialysate (Carolinas health care 
system, n.d). Toxins move from the plasma to the dialysate because of concentration 
gradients (Carolinas health care system, n.d). Toxins, having a slightly different 
concentration than dialysate, are removed as the dialysate is drained (Carolinas health 
care system, n.d). Fluid removal is through osmotic ultrafiltration by means of hypertonic 
dialysate solutions (Carolinas health care system, n.d). The two commonly variations of 
PD available are continuous ambulatory peritoneal dialysis (CAPD) and continuous 
cycling peritoneal dialysis (CCPD) (Carolinas health care system, n.d). 
Renal function. This is how efficient kidneys filter blood (National Kidney 
Foundation, 2014). This efficiency can be indicated by use GFR (National Kidney 
Foundation, 2014). Residual renal function is the urinary clearance of urea and creatinine 
(National Kidney Foundation, 2014). Marron, Remon, Perez-Fontan, Quiros, and Ortis 
(2008) defined RRF as the residual GFR among individuals suffering from ESRD. GFR 
is the generally accepted index for determining kidney function (Thomas & Thomas, 
2009). 
Assumptions of the Study 
During this study, I assumed that the data collected was accurate in both storage 
and recording by medical practitioners.  Further, it was assumed that the equipment used 
and the efficiency of the nurses or physicians did not affect the data on efficacy of the 
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two treatment modalities of PD and switching from PD to HD. Any errors from the 
medical team could cause death of a patient and thus, affect the results of the study. 
Psychological effects play a part in one’s healing and I assumed that this did not affect 
the success of the dialysis. Health lifestyles, like diet, also influenced the success rate of 
remedy but this was assumed to play no significant role in this study. I also assumed that 
innate traits of patients did not have an effect in dialysis outcome. Arguably, health 
literacy has an effect in using prescribed treatment and adhering to medical instructions. I 
assumed health literacy did not play a role in dialysis outcome. 
Scope and Delimitation of the Study 
The research problem was to establish the effectiveness of PD alone, switching 
from PD to HD (after six to 12 months) as well as establish whether social factors (age 
and gender) and medical conditions (diabetes and cardiovascular disease) play a role in 
improved renal function. The efficacy of switching from PD to HD can only be 
established by comparing with the GFR scores of PD and after switching to HD. This 
objective was achieved by use of the discussed research design and consequent data 
collection and analysis.  
In line with the study objectives, the efficiency of HD, PD, and switching from 
PD to HD affects a patient’s life, which could result in mortality (Suzuki et al., 2012). 
Further, the success of the methods is affected by social factors (such as age and gender) 
and the presence of diseases (diabetes and cardiovascular disease). This shows that there 
is a causal effect relationship between method used and mortality, social factors, and 
other diseases. The scope for this study was to establish causal effect relationships. The 
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analysis of efficacy of separate methods facilitated the comparison with the effect of 
switching from PD to HD to answer the research questions. The capture of social 
economic data helped the researcher to determine their role in the technique failure.  
The population target of the study was ESRD patients whose data has been 
captured by National Dialysis Center database. The data included ESRD patients with 
diabetes and cardiovascular disease. I believe that the characteristics of this ESRD 
patients captured represented the big picture of other ESRD patients and enabled the 
researcher to draw a generalized conclusion. 
Limitations of the Study 
The use of secondary method of data collection poses challenges and eventually 
affects validity of the research outcomes. In many cases, it becomes difficult to trace data 
from databases (Vartanian, 2010). I used key search terms to locate data from the 
National Dialysis Center database. The main limitation of secondary data is that the data 
may be general and vague according to what the researcher needs (Vartanian, 2010). The 
researcher is forced to make decisions based on assumptions and unsupported evidence 
which may lead to incorrect conclusions (Vartanian, 2010). The general sources of 
information in a research may dilute the whole research process unnecessarily as the 
decisions made from that specific research might lead to affecting wrong information. 
To add on the limitations of secondary data, Whiteside, Mills, and Mccalman 
(2012) argued that available data may be too little to generate all the information required 
to come up with a concrete stand on the decision to make. To correct these limitations of 
secondary data, I employed key search terms to locate data from the National Dialysis 
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Center database. These facilities have large amounts of information which is well 
researched on and accurate besides being most current. 
Significance of the Study 
The objective of this study was to examine whether the timing of the switch from 
PD to HD is more effective on maintaining renal function than PD or HD alone, having 
accounted for demographic factors such as age, gender and co-morbidities such as 
diabetes, cardiovascular disease (CVD). Diabetes and CVD are the most diseases present 
among dialysis patients that contribute to the highest cases of mortalities (Pajek et al., 
2014; Palmore et al., 2014; Sud et al., 2014).  
The social change implication of this study is that the findings could help patients 
and medical practitioners make an evidence-based decision on the optimal course of 
dialysis with the greatest likelihood of success. In addition, the timing of the switch from 
PD to HD has not been well studied and could help raise awareness to the importance of 
considering the temporal relationship when patients should switch dialysis techniques for 
optimal survival and quality of life. 
The finding of this study could aid in the decision-making process of patients and 
medical practitioners when evaluating for the best treatment. Moreover, it could also fill 
in a gap in the literature about the effectiveness of the switch from PD to HD. 
Summary 
ESRD patients receive treatment of PD, HD or the switching from PD to HD 
(Suzuki et al., 2012). PD and HD have different success rates across a cohort of patients 
with notably age, gender, and other conditions such as diabetes and CVD (Weinhandl et 
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al., 2010; Shen et al., 2012; Suzuki et al., 2012). Most researchers believe that patients on 
PD are more likely to have cognitive dysfunction than patients on HD with same 
characteristics (Hoshi et al., 2006). On the same issue, elderly patients receiving HD have 
greater probability of intradialysis hypotension (Stefánsson et al. 2014). Research 
findings indicated that beginning treatment with PD then followed by combining HD and 
PD is a varied way of treating patients with ESRD (Suzuki et al., 2013; Pajek et al., 
2014). However, these studies are limited in given the small sample size used. As such, I 
used a national database of 128,000 dialysis patients from National Dialysis Center to 
evaluate the effectiveness of each dialysis mode independently. I also examined 
effectiveness of switching from PD to HD as well as identified determinants associated 
with the level of dialysis technique failure 
To cater for the knowledge gaps among patients, this study provided more insight 
to the effectiveness of switching from PD to HD and in managing patients with ESRD. 
The study also sought whether social factors and medical conditions influence technique 
failure and any changes in renal function of patients with ESRD. Through my research, I 
discovered the importance of first gaining knowledge when making decisions regarding 
optimal renal replacement therapy. 
The study used a quantitative research design. The main aim of the study was to 
discover factors affecting an outcome, understanding the higher contributors in the 
outcome, discovering any interventions, and making predictions. Secondary data was 
used in this study. It has an advantage of cost effectiveness but posed limitations such as 
it was general data without detail, most of the data sources were outdated, and the data 
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accuracy could not be confirmed. The data limitations were minimized by employing key 
search terms to locate data from the National Dialysis Center database. These source 
databases are very popular due to their accuracy, up-to-date and large cohort size. The 
study, with regard to the increase and projected future increase of patients with ESRD 
worldwide, will have significance as its findings added to the literature available on the 
PD, HD, and switching from PD to HD modes of dialysis and further effects of social 
effects such as age and sex in its success.  
This chapter has developed the problem statement, scope, and purpose of the 
study which will be built on in chapter two wherein the literature review, theoretical 
foundation, and literature of the rationale of the conceptual model covered was provided. 
Moreover, the literature review related to key variables and concepts developed in this 
chapter are discussed in more detail in Chapter two.  
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Chapter 2: Literature Review 
Introduction 
There are more than 2 million ESRD patients in the world with 660,000 being in 
USA (National Kidney Foundation, 2016). With the advent of PD and HD therapies, 
ESRD is becoming manageable. Regardless of the dialysis modality used, preservation of 
RRF is associated with an increased survival in dialysis patients whereas technique 
failure leads to a rapid loss of RRF (Hoshi et al., 2006; Shen et al., 2012). Recent 
evidence by Stanley (2010), Shen et al. (2012), and Suzuki et al. (2012) suggested that 
switching from PD to HD may preserve RRF longer than either modality alone. Several 
studies have tried to identify predictors of technique failure and switching technique 
success but the results have been limited by the size and scope of available dialysis 
patients (Shen et al., 2012; Suzuki et al., 2012). In this study, I used  a national database 
of over 128,000 dialysis patients to evaluate whether the timing of the switch from PD to 
HD is more effective on maintaining renal function than PD or HD alone. Additional 
variables of interest such as demographic factors (age, gender) and comorbidities 
(diabetes, cardiovascular disease) significantly improve renal function and survival times 
for ESRD patients compared to either PD or HD alone. Comorbidities in ESRD patients 
have been discussed to comprise of diabetes, hypertension, cardiovascular diseases, and 
anemia, among others (Zha & Qian, 2017). However, the comorbidities of interest in my 
study were diabetes and hypertension. 
According to the National Kidney Foundation (2014), RRF is an indication how 
efficiently kidneys filter blood. This efficiency can be indicated by a number of ways, 
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such as use of GFR. The GFR is measured in mL/min and is usually standardized to a 
body surface area of 1.73 m2 (National Kidney Foundation 2014). For an adult aged 20-
29 the normal GFR is 116 and it decreases as age increases to normal GFR of 75 for 
those aged 75 and above (National Kidney Foundation, 2014). A number of factors such 
as age, gender, height weight, and race affect GFR given the differences in mass muscle 
(National Kidney Foundation, 2014). As such, there are different measures that are based 
on the named factors. 
PD and HD are the most common modes of intervention in treatment of ESRD 
patients. Both modes of treatment have different advantages and disadvantages and 
impact on a patient’s physical, psychological and social health differently (Sam, Kovacic, 
Radic, Ljutic, & Jelicic, 2012). Well-nourished and medically stable patients on PD are 
more likely to have cognitive dysfunction than patients on HD with same characteristics 
(Sam et al., 2012). Elderly patients receiving HD have a higher probability of 
intradialysis hypotension (Sam et al., 2012). The choice of dialysis mode is influenced by 
a number of factors including financial capability of patient and the opinion of physician 
(Abraham et al., 2012). Recent studies have indicated that socio-demographic factors and 
presence of other diseases play a role in the success of dialysis. Age, for instance, is a 
major contributor to the success of dialysis (de Melo et al., 2016; Franco & Fernandes, 
2013). Theofilou (2012) noted that there are different score systems for kidney disease 
quality of life (KDQOL) based on age, occupation, gender, marital status, and 
educational level. McDonald, Marshall, Johnson, and Polkinghorne (2009) revealed that 
HD increases survival rates in older patients while PD increases survival rates in younger 
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patients. A similar study was conducted by Weinhandl et al. (2010), who demonstrated 
that PD plays a critical role in enhancing the survival rate of patients less than 65 years. 
New patients suffering from ESRD who select PD as their initial intervention strategy, 
are likely to be younger when compared with those starting with HD (Weinhandl et al., 
2010). There are similar findings by Shen et al. (2012) who noted that socio-demographic 
such as age,  gender, and presence of other diseases such as diabetes and CVD play a role 
in the success of dialysis treatment of patients. 
Studies have been conducted to examine the influence of chronic diseases on 
technique failure. Shahab, Khana, and Nolph (2006) found out that ESRD patients with 
coronary artery disease have a higher mortality rate irrespective of their diabetic status in 
PD and HD. In another study, there was no difference in survival rate of ESRD patients 
with CVD in both PD and HD (Shahab et al., 2006). Considering the advantages and 
differences in efficacies, PD and HD can be used in an integrated mode, whereas PD is 
usually followed by a timely change to HD once complications arise (Shahab et al. 2006). 
The researchers concluded that management of conventional and uremia-related 
cardiovascular risk factors are essential in patients with ESRD regardless of the dialysis 
mode used (Shahab et al. 2006). 
Past studies have only explored technique failure without focusing on switching. 
Stanley (2010) conducted a study to investigate the contribution of geographic factors, 
pre-ESRD, social, medical, and demographic factors to modality assignment of new 
patients suffering from ESRD. Information for Stanley’s study was gathered from 
morbidity and mortality Wave 2 studies. The findings of this study demonstrated that the 
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selection of PD as opposed to HD was linked with lower serum albumin, fewer 
comorbidity conditions, white race, as well as young age (Stanley, 2010). Additionally, 
the study found out that patients living with someone, married, employed, and more 
highly educated were more likely to use PD as opposed to HD (Stanley, 2010). 
Balafa et al. (2011) conducted an albumin test to examine whether protein and 
peritoneal albumin losses play an integral role in technique failure. Individuals 
undergoing PD took part in their study. Their findings indicated that protein and 
peritoneal albumin losses does not influence technique failure (Balafa et al., 2011). Yu, 
Chen, and Li (2013) conducted a study to test whether or not hypoalbuminemia play an 
integral role in PD and HD technique failure. The findings of their study indicated that 
hypoalbuminemia increases complication in patients undergoing both PD and HD (Yu et 
al., 2013). Among ESRD patients, my study provides insight into the importance of 
switching from PD to HD dialysis on hospital based patients. I also intend to expand the 
knowledge on how social-demographic factors (age and gender) and medical conditions 
(diabetes and CVD) influence technique failure and renal function of ESRD patients.  
One of the central objectives of my study was to examine whether the timing of 
the switch from PD to HD is more effective on maintaining renal function than PD or HD 
alone. The purpose of this chapter is to provide a review of related literature that would 
serve as the basis for a framework for subsequent data collection and data analysis. In 
order to develop a framework that incorporates the relevant studies necessary to 
understand the existing literature about PD and HD of ESRD patients, the review is 
divided into different sections, with subsections. The chapter begins by describing the 
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literature search strategy used. The theoretical framework guiding the study and the 
conceptual framework is then detailed This is followed by review of extant studies with 
regard to ESRD including the history of ESRD, causes of ESRD such as diabetes and 
hypertension, and treatment of ESRD including transplant, HD, PD and shift from PD to 
HD. The chapter also includes information on technique failure, the choice between 
different modalities, a comparison of HD and PD in adults, and the outcome of dialysis. 
The chapter concludes with a summary. 
Literature Search Strategy 
The chapter presents an in-depth review of literature pertinent to the research 
problem. The literature review was conducted by reviewing scholarly and peer-reviewed 
journal articles, dissertations, and seminal literature. They were obtained from PubMed, 
Ebscohost, Proquest general Google search, and Google Scholar. I used key terms, 
namely, end of stage renal disease (ESRD), peritoneal dialysis, hemodialysis, “renal 
function , causes of ESRD, technique failure, clinical outcomes of patients on dialysis, 
switching from hemodialysis to peritoneal dialysis, preservation of renal function, factors 
affecting dialysis outcome, mortality rate of ESRD patients on dialysis  and clinical 
outcomes of patients on dialysis. The literature review yielded 182 related articles, but 
upon further scrutiny only 112 were relevant to the study hence used and cited. The study 
has 92 articles including in the literature review, published within the last 5 years. 
26 
 
Theoretical and Conceptual Framework 
Biopsychosocial Model 
The biopsychosocial model details the importance of understanding human health 
and illness in their fullest contexts (Frankel, Quill, & McDaniel, 2003). According to 
Frankel et al. (2003), the biopsychosocial model intends to systematically consider 
biological, psychological, and social factors and their complex interactions in 
understanding the illness, health, and health care delivery. In the biopsychosocial 
approach, humanistic qualities are highly valued involving the application of the 
scientific method to diverse biological, psychological, and social phenomena as related to 
human health (Frankel et al., 2003). To apply the biopsychosocial approach effectively in 
a clinical practice such as treatment, one has to recognize that relationships are central to 
providing health care, use self-awareness as a diagnostic and therapeutic tool, elicit the 
patients’ history in the context of life circumstances, and provide multidimensional 
treatment (Janowski, 2009). Lastly, those applying this approach must also decide on the 
aspects of biological, psychological, and social domains which are most important in 
understanding and promoting the patients’ health (Janowski, 2009). 
Several studies were found that used the biopsychosocial model. Maribo, 
Melchiorsen, Rubak, Jespersen, and Nielsen (2014) described the core themes in modern 
rehabilitation and how the psychosocial model can be used to improve the practice. The 
psychosocial model can be used to highlight barriers connected to rehabilitation such as 
practical barriers, economic barriers, social barriers, and lack of resources (Maribo et al., 
2014). Maes and Twisk (2010) reviewed the model proposed by Havey and Wessely 
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(2009) about the biopsychosocial explanatory model for myalgic 
encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, the conclusion of the 
authors was that a bio psychosocial model based upon IO and NS abnormalities is likely 
more appropriate to treat the complex disorder (Maes & Twisk, 2010). Some authors also 
stated that the biophysical model also has disadvantages (Ghaemi, 2009; Benning, 2015). 
Harding, Campbell, Parsons, Rahman, and Underwood (2010) also stated that pain clinics 
using a biopsychosocial model of pain management may not be achieving their maximum 
potential.  
The section provides an overview of literature in regards to the purpose of the 
study which focuses on determinants of switching from PD to HD and determining 
whether timing of switch improves renal function among ESRD patients. The literature 
search strategy yielded 115 studies that were cited in the literature section including those 
within the last 5 years. Literature showed that factors determining switch from PD to HD 
were age, gender, marital status, diabetes and CVD. Age was considered a significant 
factor in determining the switch where younger patients perform better in PD while 
elderly in HD. Diabetes and CVD greatly contributed to switch from PD to HD. My 
study was guided by the use of bio-psychosocial model that aided in operational 
definition of study variables.  
Conceptual Framework 
The conceptual framework illustrates the hypothesized relationships among 
patient’s characteristics, the health status, the patients with ESRD experiences, and the 
social economic factors associated with patient’s satisfaction and health status. These 
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constructs were used to relate how ESRD patient’s characteristics and modalities for 
treatment (PD, HD, or transition from PD to HD) influence the outcomes. I investigated 
the impact of determinants such as demographic, socio-economic, and health status 
factors on treatment technique failure. According to Harding et al. (2010), the 
socioeconomic and other conditions on the body of the patients with the ESRD disease 
are identified as cofounders of the association between health status and patient recovery. 
Figure 1 illustrates the bio-psychosocial model. 
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Figure 1. Conceptual framework. 
The biopsychosocial model holds that a patient’s clinical outcome is influenced 
by social context and biological factors (Frankel et al., 2003). The biological facets 
include infections, physical trauma, nutrition, and hormones, which are tied to gender and 
genetics (Frankel et al., 2003). According to the biopsychosocial model, it is the 
interaction between an individual’s genetic makeup, their biology, and socio-cultural 
environment which contributes to illness or health. (Frank et al., 2003) The 
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biopsychosocial model demonstrates that each one of these factors is not adequate to 
bring about health, but the interaction between them defines the progression of one's 
health development (Lane, 2014). In this study, the outcome of ESRD patients on dialysis 
is influenced by patients’ biological and demographic factors, as well as the presence of 
other diseases.  
The social-economic factors in the conceptual framework, such as educational 
background, are significant in the ESRD patient health outcome, which is an important 
predictor of treatment success (Hampton, 2011). ERSD patients with more education 
have a greater likelihood to possess better health literacy, helping them to gain social 
skills needed to gain access, understand and use health information as prescribed 
(Hampton, 2011). Connected to the conceptual framework, Secker (n.d) argued that low 
health literacy correlates directly to the poor health status. Limited knowledge on medical 
conditions leads to decreased comprehension of medical information, poor compliance 
rates to the set guidelines, poor self-reported health, and increased health related costs 
(Secker n.d). Health literacy is important in the dialysis population due to educational 
disparities between PD and HD patients and the transfer from HD to PD diagnosis. 
Individuals with a high education level may be placed on the PD, which requires more 
knowledge in order to understand the complexities of the procedures involved 
(Sinnakirouchenan & Holley, 2011). Patients undergoing PD may be more assertive and 
autonomous in the decision-making process compared to those receiving HD 
(Sinnakirouchenan & Holley, 2011), emphasizing the point that health literacy is an 
important variable in determining technique failure . 
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CVD is one of the health status factors determining the outcomes of dialysis in 
ESRD patients (Buvanendran, Leong, & Deer, 2013). The significance of CVD in ESRD 
patients is increased by the accelerated atherogenesis, endothelial dysfunction and 
inflammation, and lipid derangements (Buvanendran et al., 2013). According to Zyga and 
Kolovos (2013), patients with ESRD suffering from cardiovascular conditions such as 
arrhythmias, CVD, coronary artery disease, and peripheral vascular disease, have a worse 
outcome after dialysis when  compared to patients with ESRD without CVD. 
Cardiovascular conditions in treating ESRD patients affect the outcomes after using PD, 
HD, or PD to HD dialysis. HD has been identified to result to better outcomes in 
cardiovascular patients compared to PD dialysis (Zyga & Kolovos, 2013). 
Theoretically, as PD results in good outcomes, it should be presented to patients 
with cardiovascular conditions to improve blood pressure control and avoidance of 
uremic peaks and less hemodynamic stress (Zyga & Kolovos, 2013). This statement has 
invited some criticism as some researchers have suggested that PD promotes a 
proatherogenic environment (Van Biesen, Verbeke, & Vanholder, 2007; Bhowmik & 
Tiwari, 2012; Li, Ng, & Mcintyre, 2017). To add to this, ultrafiltration failure and the 
development of high transport membrane permeability in the process of treatment 
contributes to hypertension, cardiomyopathy, and fluid overload among the PD treated 
patients (Zyga & Kolovos, 2013).  
Diabetes has been highlighted in the conceptual framework as one of the 
determinants of the outcomes of patients with ESRD after dialysis. The outcomes of PD 
in patients with diabetes changes according to the treatment modality as well as other 
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factors such as the age and gender of the patient (Wang et al., 2013). According to the 
majority of studies and researches done, diabetic patients using PD have more 
encouraging outcomes compared to diabetic patients using HD (Wang et al., 2013). 
Treatment of ESRD under PD and HD have thus, been attributed to more positive 
outcomes than HD. Patients under PD have better outcomes than HD. CVDs are among 
the causative factors for mortality in patients with ESRD. The traditional risk factors of 
ESRD include diabetes, hypertension, and dyslipidemia (Liu et al., 2014). The most 
causative factors for chronic kidney disease and ERSD are hypertension and diabetes 
(Abu-Odah, Abed, El-Khateeb, Salah, & El-Nems, 2016; Ghaderian, Hayati, Shayanpour, 
& Mousavi, 2015; Liu et al., 2014). CVDs account for 50% of the deaths for patients 
undergoing dialysis due to chronic kidney disease (Kumar, Bogle, & Banerjee, 2014). 
Moreover, the prevalence of mortality of ESRD patients in the United States was 20% 
higher for patients with CVD as compared to patients without CVD (Liu et al., 2014). 
Hypertension was observed to be the most common cause of death with approximate 2.33 
million of total cardiovascular deaths and 1.27 million premature cardiovascular deaths 
were associated with hypertension among patients in China (Liu et al., 2014). The CVD 
are more prevalent in men than in women (Liu et al., 2014). Hypertension, in this study 
have been considered as major risk factor for ESRD and its prevalence continues to cause 
mortalities among the affected patients. CVDs cases are thus, high in US. 
In addition, diabetes D accounts for 45% of the known cases of ESRDin the 
United States (Ghaderian et al., 2015). Similarly, for Germany and Austria, diabetes 
accounts for 34% and 30% for ESRD, respectively (Ghaderian et al., 2015). Diabetes is a 
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leading cause of ESRD cases in Middle Eastern countries whereby approximately 35% 
cases of patients aged 40 years and older were observed in Iran, 26.6% in Saudi Arabia, 
21.2% in Kuwait, 35% in Egypt, and 48.6% in Lebanon (Ghaderian et al., 2015; Abu-
Odah et al., 2016). The survival rate of diabetic patients is lower than nondiabetic 
patients regardless of dialysis modality (Ghaderian et al., 2015). Diabetes and age have 
thus, been pointed out as the major factors leading to ESRD. Diabetes is prevalent in 
developed countries which reflect an increased percentage of ESRD patients.  
The conceptual framework also indicates gender as a significant factor 
contributing to the outcomes of PD, HD, or PD to HD treatments to patients with ESRD. 
Female patients with ESRD exhibit the biggest difference in life expectancy compared to 
their counterparts without the disease. According to Yeates et al. (2012), dialysis therapy 
reduces greatly the survival advantage that women in the general population experience. 
In addition, Yeates et al. (2012) indicated that diabetic women experience poorer out 
comes in dialysis compared to diabetic men exposed to the same conditions and treatment 
modalities.  
Age is a determinant in the outcome of dialysis among patients with ESRD. 
According to Yeates et al. (2012), PD results in better health outcomes in young patients 
with ESRD while HD results to better outcomes in the elderly and this is reflected in 
diabetic patients. The consideration for age differences is of significance as individuals 
receiving PD tend to be younger than their counterparts receiving HD. Wang et al. (2013) 
argued that when comparing PD, HD and PD to HD, it is important for adjustment of age 
where PD patients should be less than 65 years. Thereby, patients with ESRD choosing 
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PD as their initial treatment then moving to HD tend to be younger resulting to better 
outcomes and increased survival rates.  
Age is considered a significant factor during the dialysis of ESRD patients. 
Additionally, age is a contributor and risk factor of diseases such as diabetes mellitus and 
hypertension (de Melo et al., 2016; Franco & Fernandes, 2013). The demand for renal 
replacement therapy is on the rise among the elderly people who are prone to 
cardiovascular diseases which are the lead causes of chronic kidney disease. An increased 
demand for elderly people to be offered dialysis and improvement of patient’s survival 
among the aging group is required (Franco & Fernandes, 2013). It is estimated that one in 
four patients who starts renal replacement therapy in the USA is a patient aged 75 years 
or older. A similar scenario prevails in France whereby the mean age of patients engaging 
in dialysis is 70.2 years and in the United Kingdom is approximately 65 years. The 
glomerular filtrate rate decreases with increase in age where the percentage is lower for 
the elderly people (Franco & Fernandes, 2013).  
The dialysis of elderly people using hemodialysis has unique features. The elderly 
population as compared to the younger population has more co-morbidities, 
hospitalizations, drug use, and usage health services (de Melo et al., 2016). Conducting 
research for the elderly people with chronic kidney disease is important as it improves 
their quality of life. The metabolic functions, as well as psychological functions of body 
organs, decrease as the age of a person increases. Moreover, the elderly people are less 
likely to engage in physical exercises which also increase chances of chronic diseases (de 
Melo et al., 2016). The elderly as well have lower life expectancies which lead to the 
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decision to engage in dialysis for the treatment of renal replacement therapy (Segall et al., 
2015). 
Residual Renal Function 
The Residual Renal Function for patients with End Stage Renal Disease is the 
capability of native kidneys to emanate water and uremic toxins (Roszkowska-Blaim & 
Skrzypczyk, 2013). The renal residual function is associated with parameters such as 
Glomerular Filtration Rate. The Residual Renal Function does not have a common 
method of measurement but it is based on daily dieresis which is a scale for body mass or 
body surface area in children. The patients with ESRD receive the renal replacement 
therapy. The residual renal function is important to children because it does not only help 
preserve adequacy of renal replacement therapy but also lower the risk of adverse 
myocardial changes, fasten the growth rate, enhance treatment of anemia and calcium-
phosphorus balance abnormalities as well as improve nutrition and blood pressure control 
(Roszkowska-Blaim & Skrzypczyk, 2013).  
Residual renal function in PD and HD. Studies indicate that engagement in HD 
mode results in the increased rate of loss of residual renal function compared to patients 
engaging in peritoneal dialysis. In addition, a study indicated that patients observed a 
greater loss of residual renal function on the onset of initiating treatment with HD than 
those who had not (Curran & Bargman, 2011). The loss of residual renal function in PD 
is associated with malnutrition whereas the maintenance results in better nutrition 
statuses. The preservation of residual renal function for ESRD patients in PD dialysis in 
overall enhances patient’s survival rates (Curran & Bargman, 2011). The residual renal 
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function is also an important aspect in patients under hemodialysis mode. The residual 
renal function contributes to the total solute clearance which specifically aids in removing 
middle as well as small solute proteins (Xydakis et al., 2013). Residual Renal Function 
aids by maintaining balance in residual homeostasis mechanism for calcium and 
phosphorus balance, optimal control of fluid balance, reduction in cardiovascular diseases 
as well as the reduction in left ventricular hypertrophy. The residual renal function 
improves the quality of life by increasing the hemoglobin status in blood and better 
phosphate control. The PD dialysis preserves residual renal function better than HD 
dialysis does (Xydakis et al., 2013). The measurement of residual renal function is the 
glomerular filtrate rate which exhibits a causal relationship with mortality of end-stage 
renal disease of patients. A study conducted by Wal et al. (2011) indicated there was no 
difference observed for end-stage renal disease patients starting dialysis on either PD or 
HD. However, the study concluded that the decline of RRF is slower in patients who 
receive PD as compared to HD. Hence, PD is preferred in preserving residual renal 
function than HD in end stage renal disease patients. 
Benefits of maintaining residual renal function. There are many benefits 
associated with maintaining residual renal functions in patients with ESRDs. The residual 
renal function helps patients maintain dialysis by improving survival and quality of life. 
The improvement in quality of life for ESRD patients undergoing dialysis is enhanced 
due to the constant clearance of solute as well as managing volume control (Mathew, 
Fishbane, Obi, & Kalantar-Zadeh, 2016). There are few studies examining the effect of 
residual renal function on the outcomes of patients undergoing Hemodialysis. One of the 
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main rationales for the paucity of studies examining the effect of residual renal function 
on the outcomes in patients undergoing hemodialysis is that there are challenges of 
accurate interdialytic urine collection from patients using hemodialysis. Moreover, 
research has shown that residual renal function declines rapidly in hemodialysis patients 
as compared to peritoneal dialysis (Mathew et al., 2016). The use of hemodialysis 
preserves residual renal function longer as compared to patients under peritoneal dialysis.  
The residual renal function is important as it leads to control volume, balancing of 
minerals and electrolytes, leads to less inflammation as well as enhances effective 
clearance of protein-bound solutes and middle molecules (Mathew et al., 2016; Patel & 
Hu, 2015). The preservation of residual renal function lowers mortality rates for dialysis 
patients. A study conducted by Canada USA Peritoneal Dialysis (CANUSA) indicated 
that a 12% lower risk of death was observed for every incremental rise of estimated 
glomerular filtrate rate (eGFR) of 5 1/week/1.73 m2. Moreover, a 36% reduction in 
mortality was associated with the daily urine volume >250 ml alone (Patel & Hu, 2015). 
The rate of residual renal function decline is observed to decline faster among 
hemodialysis patients compared to patients on peritoneal dialysis. The decline in 
glomerular filtrate rates among the patients under peritoneal dialysis ranges widely from 
1% to 8% per month while in hemodialysis patients, the rate ranges between 6% and 11% 
per month. In addition, the preservation of residual renal function is observed among the 
patients who start dialysis early. The patient’s survival under HD dialysis with residual 
renal function is higher as compared to those without residual renal function (Patel & Hu, 
2015). Cadnapaphornchai and Teitelbaum (2014) indicated that preserving residual renal 
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function has a positive effect on morbidity and mortality. The preservation of residual 
renal function is associated with improved control of complications related to chronic 
kidney disease as well as decreasing mortality rates.  
Predictors for changes in residual renal function. The residual renal function 
among peritoneal dialysis patients increases to higher volume removal while the renal 
function decreases due to the onset of diseases such as hypertension. The presence of 
hypertension diseases leads to volume overload that contributes to increased residual 
renal function (Tian et al., 2016). Moreover, the fluid overload among PD patients is 
attributed to old age, increased percentage of diabetes, increased co-morbidities, blood 
pressure as well as malnutrition. The fluid variation is an important factor in determining 
the decline of residual renal function (Tian et al., 2016). Mathew et al. (2016) also 
indicated that demographic characteristics, co-morbid diseases, and the characteristics of 
dialysis patients are among the factors contributing to the decline in residual renal 
function. Cadnapaphornchai and Teitelbaum (2014) indicated that the decreased left 
ventricular hypertrophy and hypertension among the end stage renal disease patients 
contributes to a reduction in residual renal function. The adequate and satisfactory control 
of hypertension that is associated with creatinine and urine clearance leads to the decline 
of residual renal function. The decreased intake of protein is considered as a risk factor 
for morbidity and mortality among end-stage renal disease adults. Thus, the residual renal 
function also affects the nutrition status of the patients undergoing dialysis. Moreover, 
preserved residual renal function controls anemia in ESRD patients (Cadnapaphornchai 
& Teitelbaum, 2014). 
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Strategies for improving long-term survival in peritoneal dialysis patients. 
Prevalence of the end stage renal disease (ESRD) will continue to rise in most countries 
even with the advent of new treatment methods of kidney problems. The mortality rates 
of patients with the conditions have fallen over the years, but long-term survival of 
patients with the disease has been a challenge. Cardiovascular diseases account for most 
deaths in ESRD patients. Lowering of risk factors such as the co-morbidity does not 
account for reduced mortality in patients. Kendrick and Teitelbaum (2010) indicated that 
strategies such as preservation of residual renal function, reducing the rate of infections, 
and maintaining peritoneal integrity can help to maintain the long-term survival in 
peritoneal dialysis patients. The preservation of RRF and Peritoneal Membrane integrity 
have resulted in longer survival terms of ESRD patients since factors such as age and 
cardiovascular diseases in ESRD patients cannot be controlled. In addition, integration of 
Angiotensin-Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers 
(ARBs) with hypertensive patients will lead to the preservation of RRF in diabetic and 
chronic patients (Kendrick & Teitelbaum, 2010). Hence, reduced cases of infections that 
contributes to longer survival of ESRD patients.   
Chaudhary (2011) indicated that survival rates of ESRD patients on peritoneal 
dialysis can be increased by educating patients and medical staffs, maintaining and 
managing peritonitis, the ultrafiltration failure and managing catheter-related 
complications as well as improving the adequacy of dialysis. The constant intake of 
glucose concentration which acts like an osmotic agent causes changes in the membrane 
over time and thus leads to membrane failure. The use of newer biocompatible solutions 
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without dextrose have led to less membrane damage and hence, preservation of peritoneal 
membrane. In addition, use of biocompatible solutions lowers levels of glucose 
degradation products which preserve the RRF longer. The preservation of RRF has a 
positive impact on PD patients’ survival rate (Chaudhary, 2011). The clearance of 
mediated molecules and protein bound substances by use of renal replacement therapy 
increases the survival rates of end stage renal disease patients. The renal replacement 
therapy is effective for most patients engaging in peritoneal dialysis mode. The regulation 
of blood pressure in patients with cardiovascular diseases by maintaining fluid pressure 
through control of Left Ventricular Hypertrophy regulates the renal function which 
assures for prolonged survival rate (Curran & Bargman, 2011).  
Peritoneal dialysis is associated with the advantages of higher quality life, 
preserved residual renal functional as well as increased in cost saving. In addition, 
patients are expected to survive longer in PD than in HD. Patients are expected to survive 
longer under the treatment of peritoneal dialysis through the adoption of better family 
support, stronger receptivity to dialysis, and higher cognition of dialysis (Chiang et al., 
2016). The patients faced with chronic kidney diseases are expected to gain improved 
survival rate once they receive early nephrology referral and multi-disciplinary pre-
dialysis education. In addition, Nongnuch et al. (2015) emphasized that preservation of 
residual renal function for the patients with chronic kidney disease positively affects their 
survival rates. The urine collections in most centers enable the treatment of patients in the 
peritoneal dialysis which is common as compared to hemodialysis. Similarly, patients 
under the peritoneal dialysis are at risk of attracting a variety of hypertonic dialysate and 
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episodes of peritonitis. Regulating the rate of loss of residual renal function by use of 
modality prescriptions, over ultrafiltration of fluids and use of bio-incompatible fluid 
dialysis will prolong the survival rates of peritoneal dialysis patients (Nongnuch et al., 
2015). 
End Stage Renal Disease 
End stage renal disease (ESRD) is the gradual onset of sudden or permanent 
failure of the kidney (American Nephrology Nurses Association, 2011). The human 
kidney is responsible for cleaning body wastes and maintains balance of electrolytes and 
fluids by coordinating effects on the heart and blood vessels (Smith, 2013). Currently 
there are 1.9 million people worldwide who are undergoing ESRD treatment (Anand, 
Bitton, & Gaziano, 2013). 
Kidney disease causes damage to the nephrons through stressors such as 
hypertension and diabetes. Passing urine less than often normal or more often than 
normal, vomiting, nausea, loss of appetite, feeling tired , increased difficulty in breathing, 
swelling in the face, feet and hands and itchy skin are some of the symptoms that the 
kidneys are not functioning properly (National Institute for Health and Clinical 
Excellence, 2009). 
Kidney failure is categorized into two depending on how fast the failure occurs. 
Acute renal failure is sudden failure that can be caused by poison or drug that can make 
the kidney to fail, accident, abrupt loss of blood or very low blood pressure (Carolina 
Health Care System, n.d). If the kidney failure is gradual then it is called chronic renal 
failure, which can be caused by unattended high blood pressure or unsuccessfully 
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controlled diabetes. Chronic kidney failure develops into ESRD. Renal function panel, 
biopsy, and 24- hour creatinine clearance are some of the clinical tests that can be done to 
ascertain functionality of the kidney (National Kidney Foundation, 2015). The main 
causes of kidney failure are diabetes and hypertension but infections that affect the 
nephrons, trauma, and birth defects are other causes though they are rare (Carolina Health 
Care System, n.d). The causes of ESRD vary with social factors such as race, ethnicity, 
and age (American Nephrology Nurses Association, 2011).  
 There are two modes of treating kidney failure namely; kidney transplant and 
dialysis. Dialysis is the cleaning of blood either inside or outside the body by use of 
machine while transplant is the receiving of live kidney from a donor (National Kidney 
Foundation, n.d). These methods will be discussed in detail in other parts of the literature 
review. The choice of treatment, mode depends on lifestyle, personal preference, and 
medical condition of patient. 
Diabetes as a Cause of ESRD. Diabetes is the leading cause of ESRD as per data 
provided by the American Nephrology Nurses Association (2011). In the US, there were 
25.8 million diabetic Americans where diabetes accounted for 44% of the kidney failures. 
Diabetes is the shortcoming of the body to utilize glucose (Redmon et al., 2014). Passing 
urine often, having dry itch skin, having blurry eyesight, feeling very tired and hungry 
often, losing weight unintentionally, and slow healing of wounds are some of the 
symptoms of diabetes (National Kidney Foundation, 2013). They are two types of 
diabetes namely; diabetes type 1 and diabetes type 2. In type 1 diabetes, the cells of the 
pancreas fail to secrete insulin as that have been destroyed due to the failure in the 
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immune system of the body (Center for Disease Control, n.d). Diabetes type 1 is treated 
by getting insulin injections, nutrition, physically activeness and controlling cholesterol 
consumed and blood pressure. Diabetes type 2 is the failure of the body to properly 
utilize the insulin generated by the pancreas. Obesity and lack of physical activity 
increases the chances of diabetes. 
There are almost equal rates of kidney failure in both types of diabetes (American 
Nephrology Nurses Association, 2011). However, some groups are at a higher risk of 
kidney failure if they also have diabetes. Those with high blood pressure, more than 65 
years old, are Hispanic Americans, African-Americans, Asians, American Indians, or 
Pacific Islanders and have a family member who has kidney disease, have higher chances 
of having kidney failure (National Kidney Foundation, 2013).  
Fox et al. (2012) conducted a meta-analysis of studies selected according to 
Chronic Kidney Disease Prognosis Consortium criteria. The authors used Cox 
proportional hazards models to approximate the hazard rations (HR) of mortality and 
end-stage renal disease associated with albuminuria and eGFR in individuals with and 
without diabetes. The authors analyzed data of 1, 024, 977 participants (128, 505 with 
diabetes). The authors concluded that kidney disease is an important predictor of clinical 
outcomes. 
There are high or low glucose levels in the blood for diabetic patients due to the 
low insulin levels or lack of utilization of the insulin produced by the pancreas. With high 
glucose levels, the kidneys are forced to work harder in the filtration process to maintain 
the necessary glucose levels. The extra effort required may cause the vessels in the 
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kidneys to give way consequently allowing loses of protein in the urine. This continuous 
strain of the kidney eventually results in loss of ability to function effective and lead to 
development of end stage renal disease (ESRD). 
The damage caused to the nervous system by diabetes also causes or accelerates 
kidney failure. Nerves transmit messages to all other body parts and the brain including 
the kidney and its parts like the bladder letting one know when it is full. If the nerves are 
damaged one cannot know when the bladder is full and the pressure accumulated from 
full bladder can damage the kidney (National Kidney Foundation, 2013). If urine stays 
for long in the bladder there are chances the urinary tract will be infected due to the 
bacteria in the urine. With high sugar level, bacteria will grow rapidly and can cause 
infections to the bladder which will spread to the kidney (National Kidney Foundation, 
2013). 
Despite being the lead cause of kidney failure, the progression of kidney failure 
can be slowed in diabetic patients. As per the guidelines of the National Kidney 
Foundation (2012) this can be achieved by treating hyperglycemia which is the defining 
failure in diabetes that causes organ complication such as kidney failure. Thorough 
treatment of hyperglycemia averts elevated albuminuria and slows down the progress. 
The downside of this remedy is that patients are at an increased risk of severe 
hypoglycemia. 
Based on the glomerular filtration rate and assessments of urine albumin, the 
development of kidney disease that results in ESRD has been categorized into five stages 
(American Association of Diabetic Educators, 2013). In the first stage, there is evidence 
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of kidney ineffectiveness but with a normal glomerular filtration rate whereas in the 
second stage, kidney ineffectiveness increases accompanied by a decrease in levels of 
glomerular filtration rate to 60- 90 milliliters in a minute. In both stage one and two, there 
are not many symptoms however, there may be protein or blood on the urine, high blood 
pressure, and more than normal levels of End stage renal disease. In stage three, 
glomerular filtration rates further reduces to 30 to 59 milliliters per minute with a further 
dip in glomerular filtration rate to 15 to 29 ml/ml, which is severe. At this stage, there 
will be fatigue, reduction in ability to concentrate, difficulty sleeping especially at night, 
and loss of sexual drive. In the fifth stage, there is obvious evidence from very low 
glomerular filtration rate of 15ml/min accompanied by nausea, continuous illness, 
itching, inverted sleeping pattern, fat and muscle loss, and skin coloration (American 
Association of Diabetic Educators, 2013). 
Hypertension as a Cause of ESRD. Hypertension is the second common cause 
of kidney failure (Carolina Health Care System, n.d). By 2011, sixty-six percent of ESRD 
patients had hypertension (American Nephrology Nurses Association, 2011). 
Hypertension is a condition with blood pressure of more than 140/90 mmHG (University 
of Cambridge, 2009). Hypertension can be controlled by changes in lifestyle which 
include, reduced sodium intake, losing weight, alcohol moderation, being physically 
active, reduction of intake of saturated fat and smoking cessation. If lifestyle modification 
fails, antihypertensive drugs are used. The risk of getting ESRD in hypertension patients 
varies with age, body weight, and ethnicity where older persons, over weight are at a 
higher risk and there are those with family history. 
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The cause of kidney failure by hypertension is increased blood pressure that 
damages the nephrons and the association of hypertension to diabetes and vascular 
diseases, extracellular volume changes, chronic inflammation, and adjustment of 
cardiovascular dynamics. Smith (2013) noticed that there is a greater effect on kidney 
disease due to higher systolic pressure, than for pulse blood pressure, or diastolic blood 
pressure. Mahmoodi et al. (2012) conducted a meta-analysis of 45 cohorts (25 general 
population, seven high-risk, and 13 chronic kidney disease) with 1,127,656 participants, 
364,344 of whom had hypertension. The authors contended that chronic kidney disease 
should be considered as at least an equally relevant risk factor for mortality and ESRD in 
individuals with or without hypertension. 
For hypertensive patients with kidney failure, multiple antihypertensive agents are 
used to attain require blood pressure of below 130/80 mmHg. RAAS inhibitors are one of 
the most used antihypertensive agents (Smith, 2013). Medical guidelines propose (ARBs) 
angiotensin receptor blockers or ACEi (Angiotensin Converting Enzyme inhibitors) to be 
the first preferred treatment in slowing down the progression of kidney disease in persons 
with hypertension (Mount, 2012). Aldosterone 91012 has been associated with renal 
injury development of chronic kidney disease due to high aldosteroine escape as a result 
of high blood pressure, increased vascular inflammation, fibrosis, oxidative stress, 
sympathetic nervous system and apoptosis (Maron & Leopold, 2010; Smith, 2013). There 
is need to use aldosteroine antagonist as a remedy to inhibit enjoining of aldosterone with 
the mineral corticoids receptor. However, there are concerns of using agents in slowing 
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progression of kidney failure as they have been found to be associated with increases in 
chances of hyperkalemia. 
There are factors that contribute the progression of simple kidney malfunction to 
ESRD in patients with hypertension. Visceral obesity activates a series of maladaptive 
renal, cardiovascular, prothrombotic, inflammatory and metabolic responses; a number of 
which  form the cardio-metabolic syndrome (Saito et al., 2013). These responses 
including dysglycemia, hyper-insulin resistance, dyslipidemia, hypercortisolemia and an 
altered vascular function enhance the progression of kidney disease to ESRD. In 
hypertensive patients, insulin resistance in these patients with visceral obesity is 
associated with the characteristic of the fat in the para-intestinal and mental regions 
(Saito et al., 2013). 
Treatment of ESRD 
Transplantation, peritoneal dialysis, and hemodialysis are the available modalities 
for renal replacement therapy for the treatment of ESRD. HD is subdivided into two; 
center HD which is the most commonly used and home HD. Peritoneal dialysis (PD) 
encompasses of both continuous cycling PD (CCPD) and ambulatory PD (CAPD), along 
with other forms of PD in a small sub-group (Lewis & Noble, 2012). Renal 
transplantation is always from a living donor (either emotionally related donor or a blood 
relative) or even a cadaveric donor. During the process of being treated for ESRD, it is 
possible for the patients to severally switch between the different renal replacement 
therapy modalities. For instance, a certain patient might switch from CAPD to 
transplantation, from transplantation to HD and perhaps to another transplant. 
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A Brief History  
In the 1960’s, peritoneal, renal transplantation, and hemodialysis started to be 
commonly used to treat ESRD patients. Earlier before 1960, dialytic modalities were 
helpful to some patients who were suffering from acute renal failure. Living donor 
transplants were successfully performed to a few identical twins, but there was no other 
treatment available except dietary modification for patients with ESRD. In the early 
1960’s, some few patients for chronic renal failure were treated with hemodialysis using 
the Belding Scribner’s work. This was followed by the use of peritoneal in the 1960s 
followed by renal transplantation from twins who are not identical in the same period. 
The renal transplantation from non-identical twins was made a reality through improved 
understanding of immunology and by the use of immunosuppressive therapies (Bomback 
& Bakris, 2011). However, Medicare coverage was not enacted by this time. 
Medicare coverage for end-stage renal disease was enacted by the congress as part 
of social security amendments that eventually became effective in 1973. The reduction in 
treatment costs have been encouraged by several legislative changes made in the 
Medicare’s ESRD program through changes in modality to home dialysis and payment 
methods (Bomback & Bakris, 2011). Other changes have taken place ever since 1960s, 
remarkably outpatient erythropoietin therapy for dialysis patients and an emergence of 
immunosuppressive drugs after transplantation. 
Transplant as Treatment of ESRD. Kidney transplant is a treatment of ESRD 
where a kidney is taken out of donor and surgically placed into a recipient (Carolina 
Health Care System, n.d). A successful kidney transplant enables a patient to terminate 
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dialysis. Kidney transplant is affected by factors such a number of willing donors, 
medical condition of the recipient and the suitability of the donors (American Nephrology 
Nurses Association, 2011). A recipient must undergo evaluation to ascertain their 
suitability to undertake a transplant (Carolina Health Care System, n.d). The evaluation 
process entails meeting with a social worker, financial specialist, dietician, transplant 
nephrologists, and surgeon. The purpose of the meeting is to educate the recipient on the 
transplant process by highlighting probability of success, risk and benefits, expected 
lifestyle, diet and the financial obligation. Besides educating the recipient, lab tests and x-
rays are conducted to establish the health status of recipient. 
Once the evaluation process is completed, the transplant team reviews the 
information and makes a decision if the transplant is viable and a safe option. In the 
review, a patient with other diseases like cardiovascular diseases, cancer, or other serious 
infections has reduced chances of having a successful transplant. The transplant team will 
want to ascertain if the patient will be able to follow the schedule after the transplant 
especially in the first year, which requires regular visits to the physician (National 
Institute of Health, 2008).  
If recommended, the recipient gets an opportunity to undergo either of the two 
types of transplant. In the first option, the recipient will get a kidney donated from a live 
donor (National Institute of Health, 2008). The donor might be someone known to the 
recipient mostly family member or friend. The option of a living donor has high chances 
of success and transplant can be planned at convenient time. However, not all who need a 
transplant can get a living donor and as such can only receive kidney from a deceased 
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donor. Throughout the life of the new kidney, one must take antirejection medication 
daily in order to maintain the new kidney (National Kidney Foundation, 2012). During 
the first year after kidney transplant, the patients are monitored closely by a physician, 
after that, the frequency drops to monthly lab visits. Transplant is considered as the best 
strategy of treating End Stage Renal Disease but due to limited number of donors, several 
strategies such as hemodialysis are being considered (Naalweh et al., 2017). 
There are various advantages of undergoing a transplant chief among them being 
the ability to live a near normal life again with reduced restrictions such as those in diet. 
There are increased energy levels as new functioning kidney promotes production of red 
blood cells. Kidney transplant increases quality of life than dialysis and has better 
chances of survival where in the first five years there are seventy percent as compared to 
thirty percent in patients who have undergone dialysis. For successful kidney transplant, 
ESRD associated comorbidities like cardiomyopathy, may be resolved completely, or 
made insignificant. However, the disadvantage of transplantation is the risk of the body 
rejecting the new kidney, the increased chances of cancer; follow up especially in the first 
year and the increase risk of infections. It is observed that the success of transplant is 
affected by the time the patient spent on dialysis prior to transplant. There are increased 
chances of success with an early transplant but this depends in the chances of getting a 
live donor. 
With the increasing occurrence of ESRD and the success rate associated with 
transplant, there is bound to be regulations that govern the process and the code of ethics. 
Both the recipient and the donor have the right to receive and donate the organ (Award, 
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2013). However, commercially inspired transplant is unethical and unacceptable practice. 
The living donor is obliged to give informed consent duly signed without any undue 
influence such as finance or coercion. This happens after understanding the risks and 
benefits involved and medical evaluation of the psychological preparedness. The patient 
should not be used as a means but an end and as such there is respect for integrity, 
dignity, and authenticity (Award, 2013). The autonomy of donors should be respected 
with regards to the ability to understand information and make a decision which gives 
them a decision-making capacity which should be respected. When making the final 
decision on transplant, balance between saving life in a cost effective manner (clinical 
utility demand) and the upholding of right to donate a kidney both after death and in life 
is made (Award, 2013). 
Hemodialysis. Through the process of hemodialysis, toxins and excess fluid are 
removed via extracorporeal circulation of blood. This is done through a dialyzer or what 
is commonly referred to as “artificial kidney”. The treatments are usually scheduled for 
three times in a week and last for 3 to 4 hours (Cabral & Santos, 2012). Arterio-venous 
(AV) fistula, indwelling vascular catheter or vascular graft is used to access the vascular. 
The treatment is usually performed as “center hemodialysis” in a freestanding or hospital-
based dialysis unit. In this environment, patients’ dialyzers are often reprocessed and 
therefore a given patient may reuse the dialyzer multiple times (Cabral & Santos, 2012). 
However, this modality can be used at different locations. This process of hemodialysis 
may be performed at home (home dialysis) after the patient and the assistant undergo 
several weeks of training. The advantages associated with home hemodialysis include 
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patient independence and the dialysis scheduled meets the patient convenience (Cabral 
and Santos, 2012). Patients treated with home hemodialysis appear to enjoy a better 
quality of life and are reported to survive better compared to center hemodialysis. In the 
near past, home hemodialysis has been practiced as a daily treatment given as either slow 
nighttime dialysis (Pierratos) or short daytime (Buoncristiani). Patients under 
hemodialysis are partially responsible for the success of the success of their treatment, 
medical prescription, as well as adherence to HD sessions. The patients ensure that they 
maintain their diet in order to increase their chance of survival (Nalweeh et al., 2017). 
Peritoneal dialysis. This process uses the peritoneal membrane as a substitute 
surface dialysis. It entails placement of a catheter into abdominal cavity, and repeated 
drainage and instillation of sterile dialysate (Ronco, Rosner, Crepaldi, & International 
Course on Peritoneal Dialysis, 2012). The movement of toxins from the plasma to the 
dialysate is caused by the concentration gradients during the dwell time. The dwell times 
vary form few hours in CAPD, to up to 1 hour in other forms of cyclic PD. Toxins which 
are equilibrated with the dialysate are drained together with the toxins. The fluid is 
removed via osmotic ultrafiltration through the use hypertonic dialysate solutions. There 
are various options that can be used in PD. 
The most commonly used peritoneal dialysis option is the continuous ambulatory 
PD (CAPD). Four or five exchanges are performed daily to the patient with a dialysate of 
2-3 liters. Continuous cycling PD (CCPD) is a home treatment that utilizes a certain 
number of exchanges through a machine (cycler), every night, with a long dwell time 
during the day (Ronco et al., 2012). The combinations of both CAPD and CCPD have 
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been utilized predominantly in patients without renal function (Diaz-Buxo). Intermittent 
PD (IPD) has 3 to 7 times exchanges of dialysate weekly for 8 to 12 hours and is 
performed through the cycler (also an automated PD) Nonetheless, these options are used 
in different situations. 
The use of various options of PD favors different patients at different situations. 
CAPD and CCPD are frequently used for patients who choose the independence of self-
care and those who have difficulty with other aspects of hemodialysis or vascular access 
(Ronco et al., 2012). PD therefore has two extreme groups that are preferred for the 
procedure; the ones who are stable and independent and the ones who are unstable and 
poorly tolerant to hemodialysis. However, there is need to compare the outcomes of 
different modalities across different demographic factors. 
Choice dialysis modality. The choice of dialysis modes for ESRD patients is 
determined by geographical considerations, patient’s preferences, and medical and social 
contexts. The factors dictate the type of peritoneal dialysis mode to be used (Franco & 
Fernandes, 2013). The peritoneal dialysis mode has been used due to the factors such as 
financial constraints, cultural issues, and lack of informed consent in treating elderly 
patients. A lot of elderly patients engaging the treatment of the end stage renal disease 
prefer use of the peritoneal dialysis which are the elderly. The peritoneal dialysis has 
helped the elderly conduct physical processes to manage ESRD prevalence (Cupisti et al., 
2017). The majority of patients with chronic kidney disease prefer to start dialysis using 
peritoneal as compared to hemodialysis (Franco & Fernandes, 2013). Patients with end-
stage renal diseases are required to engage in renal replacement therapies. Different 
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medical options are available such as transplant, dialysis as well as conservative 
treatment. A significant number of the patients choose transplants and dialysis (Erlang, 
Nielsen, Hansen, & Finderup, 2015). In addition, patients intending to engage in renal 
replacement therapy through dialysis are required to engage in a timely preparation and 
education on the dialysis mode to adopt (Segall et al., 2015). Most patients opt to start 
dialysis immediately after choosing the mode of dialysis. Many nephrologists suggest 
that home-based dialysis therapies should be used among patients with Renal 
Replacement Therapies as the larger population is for elderly. In addition, many elderly 
patients have lots of co-morbid functions than the younger patients. Consequently, 
doctors and caregivers strongly suggest hemodialysis for such patients (Segall et al., 
2016). 
In addition, the choice of dialysis modality is influenced by factors such as the 
resource availability, timing of referral, unavailability of teamwork experience with 
certain dialysis modes as well as physician bias (Chiang et al., 2016). However, patients 
are more likely to choose peritoneal dialysis over hemodialysis due to its association with 
improved quality of life, reduced dialysis costs, and its relevance in preserved residual 
renal function (Chiang et al., 2016; Keating, Walsh, Ribic, & Brimble, 2014). On the 
other hand, patients do not choose peritoneal dialysis due to late referral, unplanned 
dialysis, medical factors, and time spent on modality education. Patients are likely to 
choose one dialysis modality over the other due to education on the different structures of 
the modalities (Chiang et al., 2016). Decision-making in medication among the patients is 
a tough task especially among patients with chronic kidney diseases. The decisions of 
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choosing the right path of medication are dependent on the existence of real and 
imaginary knowledge (Jayanti et al., 2015). The illness burden is as well likely to 
determine the choice of dialysis modality to be used. Moreover, clinical condition 
determines patients’ decisions to engage either in peritoneal dialysis or hemodialysis 
(Jayanti et al., 2015). 
Shift from PD to HD. Malnutrition is common in PD patients. Karen, Julie, 
Eldho, and Catherine (2011), illustrated that PD patients are attributed to decreased food 
intake and chronic inflammation linked to dialysis related comorbidities and 
complications. These phenomena advocate for a shift from PD to HD to reduce the 
prevalence of gastrointestinal symptoms in dialysis patients. The selection of PD or HD is 
usually based on the patient motivation, desire, and geographical distance from HD unit, 
physician, and the level of patient education. According to Ramapriya and Jean (2011), 
many patients are not educated on PD or HD before beginning dialysis. The study shows 
that the relative risk of technique failure in patients in PD verses HD changes over time 
with a lower technique failure risk in PD in the initial stages of dialysis. This technique 
shows continuous success in PD for up to one and a half to two years which decreases 
suddenly favoring the HD technique. Thus PD technique is best at the beginning of the 
dialysis up to about two years where the patient should shift to HD technique depending 
on the patient factors (Pike, Hamidi, Ringerike, Wisloff, & Klemp, 2017).  
Ramapriya and Jean (2011) indicated that ESRD patients’ satisfaction may be 
high with PD as the PD technique costs are relatively lower compared to the HD 
technique but a shift from PD to HD would reduce mortality rates of the patients. The PD 
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technique is more advocated for than HD technique. According to Sens et al. (2011), 
mortality rate is higher in PD technique than in HD technique. Sens et al. (2011), through 
a study, compared mortality risks in patients by dialysis modality by including all patients 
who started planned chronic dialysis with associated congestive Cardiovascular Disease 
in 933 PD patients and 3468 HD patients. There was a significant difference in the favor 
of HD technique with a survival time of thirty six months compared to survival time of 
twenty months in PD. This study concluded that there is high survival rates in HD 
patients compared to PD patients.  
TST (tuberculin skin test) response is lower in PD patients. According to a study 
conducted by Altunoren et al. (2012), which was aimed at investigating TST positive 
rates in HD and PD patients and the factors influencing TST positivity. HD patients 
indicated higher results than the PD patients. In this specific condition, the study found 
that TST is lower in PD patients especially in tuberculosis cases. 
A wide range of factors affect the uptake of PD compared to HD. According to 
Oliver et al. (2012), PD is cheaper than HD and has many potential advantages compared 
to HD technique which is more costly and contradicted. The study examined the 
differences in patient PD technique advantages compared to the benefits associated with 
HD technique. HD technique was rendered to be more contradicted besides being costly 
compared to PD technique illustrated as cheap and having a lot of potential benefits.  
Oliver et al. (2013) conducted a study with an objective to compare the risks of 
access interventions between the two modalities in a sample of 369 incidents of chronic 
dialysis patients. The study emphasized the fact that PD patients have more benefits 
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attached to the technique by concluding that patients under PD technique require fewer 
interventions to maintain the dialysis access than the patients under HD technique. 
Basing argument from the different studies, this study advocates for an integrated model 
technique. Initially PD technique should be advocated for the first two to three years and 
shifted to HD depending on the patient’s conditions.  
Chaudhary, Sangha, and Khanna (2011) and Dalal, Sangha, and Chaudhary 
(2011) conducted similar studies to establish if there is sufficient evidence to make PD 
the first therapy before switching to HD. The researchers noted that the lower cost of 
therapy, a flexible schedule, increased freedom from the patient's viewpoint, and 
convenience of home therapy are some factors that support the an ESRD patient staring 
dialysis on PD then switching to HD. Moreover, the risk of Ultrafiltration failure in PD 
and increased preservation of RRF when one has switched to HD also support the 
switching technique. However, the researchers did not conduct an empirical studies hence 
their findings are limited.  
Jaar et al. (2009) noted that technique failure is more associated with PD than HD 
and that there is little data in the United States addressing the outcomes and factors 
associated with switching modalities from PD to HD. The researchers also found that PD 
patients of black race were approximately 3 times more probable than white PD patients 
to switch from PD to HD while patients living at least 30 miles from the dialysis clinic 
were 58% less likely to switch from PD to HD likened to patients living less than 30 
miles from the dialysis clinic. Ghaffari et al. (2013) conducted a study to explore why PD 
should be the initial choice before switching to HD. The researchers noted that A “PD 
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First” approach not only has benefits for patients but also physicians, and healthcare 
systems. Patients starting dialysis for the first time often have noteworthy residual kidney 
function. The maintenance of RRF is associated with enhanced survival. Pajet et al., 
(2014) established that Peritonitis is a cause of technique failure followed by 
ultrafiltration failure. It is cost effective to start on PD then switching to HD (Chui et al., 
2013). The researchers found that patients who transitioned from PD to HD had lower 
health care costs than those who used PD or HD alone. 
The reason for switching from PD to HD can also be attributed to rising cases of 
peritonitis as well as catheter-related infections. The peritonitis infections cause the 
occurrence of ultrafiltration failure and the membrane related problems that often results 
in technique failure. The ultrafiltration failure and volume overload caused by excessive 
salt and water intake has led to the inability of maintaining adequate filtrate which leads 
to the failure of PD (Chaudhary, 2011). The prolonged exposure to hypotonic glucose 
concentrations affects the transport characteristic of the peritoneal membrane. The 
peritoneal membrane faces dysfunction due to excessive fluid and sodium intake which 
leads to loss of residual renal function and eventually peritoneal dialysis is abandoned. 
The effects of HD on ESRD patients. Peritoneal dialysis has been common over 
the past few years to the most patients undergoing treatment for End Stage Renal 
Disease, but the prevalence has decreased compared to hemodialysis. A vast number of 
ESRD patients are transferring from PD to HD where the risk of transferring to HD after 
PD initiation is highest for the first few months (Chaudhary, 2011). The transfer to HD 
affects the quality of life of patients as the transfer affects their living habits. The transfer 
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affects the lifestyles of the patients, physical health and functional status, personal 
relationships as well as social economic status (Gerogianni & Babatsikou, 2014). The 
shift to HD has been accompanied by many stressing factors such as uncertainness of 
their future, regular hospital admission, restriction of leisure time and financial 
constraints among others. The patients undergoing hemodialysis are often faced with the 
stress of low self-esteem, depression and personality disorders such as neuroticism, 
alexithymia, introversion and psychoticism (Gerogianni & Babatsikou, 2014). 
Patients on Hemodialysis find the dialysis mode stressful as it involves getting 
dialysis three times a day. The freedom of patients is undermined due to the constant use 
of machines as well as the high dependence of healthcare personnel (Nasiri et al., 2013). 
The patients on hemodialysis mode are always faced with emotional challenges. The 
patients on hemodialysis are constantly faced with physiological and psychological 
challenges due to the constant use of machines. The patients are restricted from mobility 
and face challenges in maintaining their diets. The patients are always fatigued, angered, 
and have poor adherence to treatment (Ahmad & Al Nazly, 2014). 
The patients also cope with the challenges faced during the process of obtaining 
dialysis using hemodialysis. The patients use the emotion-oriented and problem-oriented 
solving methods. The problem-oriented solving methods entails the use of planning and 
following up of active programs while emotion-oriented method involves controlling of 
emotions and adapting to the current situation (Nasiri et al., 2013). The patients as well 
cope with the challenges of undergoing hemodialysis by accepting responsibility, seeking 
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social support as well as self-controlling. In addition, the patients constantly engage 
avoidance, idealism and positive re-evaluation (Ahmad & Al Nazly, 2014). 
Technique Failure 
In some cases dialysis does not result in expected clinical outcome of managing 
ESRD. Betty et al. (2013) study design illustrated a dialysis where patients were 
categorized by initial and subsequent modality changes during the first year of dialysis 
and tracked for inpatient and out-patient costs, physical claims, and medication costs for 
at least three years using a merged administrative data set. The design determined 
unadjusted and adjusted cumulative costs for each modality group using multivariable 
linear regression models. PD technique was associated with lower costs in the period of 
one year only; however, the costs were similar to HD technique in three years. Using 
Betty et al. (2013) study one can illustrate that costs drivers in PD technique failure arise 
primarily from costs of dialysis provision, hospitalization, medications, and physician 
fees. 
Comparing the patients receiving different ESRD treatment modalities, those 
receiving HD, PD and those who transited from HD to PD therapy, all have significant 
lower total health care costs at one to three years. Patients experiencing PD technique 
failure have similar costs which might increase in the case of supporting economic 
rationale for first policy program.  
The primary technique failure in PD technique remains high. Matthew et al. (n.d), 
in his study illustrated that PD provides a safe and effective renal replacement therapy for 
regional pediatric centers that serve a rural setting where the study was conducted but 
61 
 
illustrated the technique failure rates as high as 24.6%. This was conducted from a 
population of 88 children between the ages of two days to twenty years receiving PD 
catheters for the management of acute and chronic renal failure. This study illustrates that 
though PD technique is significant in ESRD patients treatments there is still a gap to be 
filled in determination of its high technique failure rate. 
Dual incision laparoscopic surgery in PD (DILS-PD) with fixation technique is a 
simple and safe procedure. According to Yeh et al. (2013), DILS-PD procedure 
minimizes or eliminates the possibilities of migration without additional costs. Yeh et al. 
(2013) conducted a study where they performed open surgery for PD catheter 
implantation (OS-PD) and DILS-PD and then compared the information on demographic 
data, medical, operative, and postoperative findings and complication information 
between the groups. From the study there was no tube migration in the DILS-PD group 
but on the other hand there were 25.7 percent of the patients with OS-PD group with tube 
migration indicating that DILS-PD technique reduces the technique failure rate in the 
treatment for ESRD patients. From the study one can recommend for the DILS-PD as 
compared to OS-PD technique. 
Early recognition of medical deterioration and early medical intervention are 
necessary for a better outcome for elderly PD patients. According to Cheng et al. (2013), 
self-care patients experience a high percentage in the technique failure in PD technique 
compared to assisted care patients. From a study of 138 elderly ESRD patients where 
seventy were assisted care patients, it was recognized that technique survival was high 
among the care assisted patients due to the fact that early medical deterioration was 
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detected fast and the necessary measures put in place to correct the situation. These 
phenomena improved the technique survival rate. On the other hand self-care patients 
exhibited a high rate of technique failure which is associated with late recognition of 
medical deterioration circumstances reporting the incidence when it is too late. When the 
medical deterioration has already heightened to levels that cannot be corrected it leads to 
PD technique failure in the ESRD patient. The type of assisted care did not determine the 
level of technique failure indicating that the main determinant of the technique failure 
incidence was early recognition of deteriorating medical situations which were corrected 
at the appropriate time. 
On site availability of PD, case mix, funding, patient location, and reimbursement 
do not determine the technique failure in PD. According to Hingwala et al. (2013), if the 
PD attempt was maximized, a significant amount of resources can be saved or even 
directed to a much larger population of ESRD patients. Hingwala et al. (2013) conducted 
a study to examine the differences in patient PD attempt rates between nephrologists 
using technique survival and mortality as the outcomes. The highest attempt rate was 
compared with the lowest where all the results were significant. In the study while 
comparing the largest attempt and the lowest attempt it was found that the factors limiting 
PD utilization did not include case mix, funding, availability of PD and the location of 
the patient. This illustrates that PD technique failure is not facilitated by location of the 
funding which should encourage many ESRD patients to have high PD attempts to 
reduce the technique failure. 
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PD and HD are simple, safe, and efficient therapy methods. According to 
Burdmann and Chakravarthi (2011), it is possible to correct acute kidney injury and 
volume overload both in and out of the intensive care unit settings through the use of high 
volume PD and HD. Burdmann and Chakravarthi (2011) in their study advocate the use 
of PD and HD to children patients with refractory Cardiovascular Disease or 
hemodynamic ally instable conditions to reduce technique failure. 
Causes of technique failure. The technique failure results from the switching 
from one modality to another. The most common switching method in most patients is 
the switch from PD to HD where patients switch to HD due to some reasons. The major 
cause of technique failure in ESRD patients is peritonitis which occurs majorly within the 
first 1 to 2 years after initiating from PD (Chaudhary, 2011). Peritonitis causes of 
technique failure have increased from studies conducted in major dialysis centers. A 
study conducted on 292 PD patients that involved 28 dialysis centers indicated that 
24.8% of PD patients switched from PD to HD where 40% of the patients switched 
within the first one year and 70% switched within two years (Chaudhary, 2011). In 
addition, ultrafiltration, as well as volume overload, is also a major cause of technique 
failure. Patients are characterized to engage in taking large volumes of salts and water. 
The patients are therefore faced with inadequate solute clearance (Quinn et al., 2010).  
The cause of technique failure can also be attributed to the mechanical failure of 
the equipment used in performing the dialysis. The failure of the equipment is attributed 
to catheter failure which may malfunction or block. In addition, patients may have 
technique failure due to psychosocial factors accompanying the patient. Similarly, death 
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may also be a cause of technique failure where patients die due to complications accrued 
with an individual modality (Quinn et al., 2010). The early detection of the factors that 
contribute to technique failure can lead to technique survival. Patients under dialysis 
mode are often advised to monitor their infection rates, loss of renal replacement therapy 
and changes in the peritoneal membrane that help in early detection of technique failure. 
The early detection of technique failure help patients to overcome the causes of PD 
cessations, psychosocial factors as well as the reduction of mortality rates (Bechade et al., 
2014).  
The Choice between Different Modalities and the Dialysis Center 
There are two commonly used modalities of dialysis for treating patients with the 
ESRD. PD and HD are the two commonly used modalities of treatment and they differ in 
terms of techniques (Barone et al., 2014). A large number of patients suffering from 
ESRD have been on either of these two modalities of treatment. The choice of either of 
the treatment modalities depends on a number of factors. Studies conducted about the 
difference between these modalities have shown some significance difference. These 
differences are well manifested in the quality of life, social and emotional well-being 
(McDonald et al., 2009). The choice of modality treatment affects the quality of life of 
the patient. Historically, the survival of patients under HD was considered greater than 
those on PD.  
Initially, it was believed that patients who started with HD had survival advantage 
as compared to those who were on HD. Until the 1990’s some studies reported survival 
advantage of the patients who start with HD as compared to PD (Ronco, Dell’Aquila, & 
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Rodighiero, 2006). However, there was no enough literature to support this claim and 
therefore it called for enough research to be done on this field. Nevertheless, there were 
some external factors that influenced the application of HD instead of PD. 
Elderly patients who were suffering from concomitant diseases were subjected to 
PD. This was also driven by the shortage of HD units. It was also influenced by clinical 
and social contraindications that could not allow the patient to undergo HD (McDonald et 
al., 2009). However, some recent studies have indicated that there is no significant 
difference in any of the modalities. 
In the early 2000’s the patients were directed towards the treatment which was 
most beneficial to them. According to Sisca and Pizzareli (2002), there lacked a 
significant disparity in the expected survival rates between the different treatment 
methods. Both PD and HD were considered similar in terms of the expected survival for 
patients in all the ages, genders and other demographic factors. Even though HD is the 
most common modality of dialysis, it has another variant known as HDF. 
In HDF, more fluid is removed by the dialysis machine in the process of 
treatment. This implies that the blood is cleansed better. Nevertheless, the removed fluid 
has to be replaced and this calls for another session that last as long as the session of HD 
(Ronco, Canaud, & Aljama, 2007). This modality involves the use of sophisticated 
instruments and therefore it is not commonly used due to the financial constraints (Ronco 
et al., 2007). The choice between the public and private dialysis centers in United States 
is also influenced by some factors.  
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Most people who want to seek dialysis services prefer the public units. The public 
units are said to be more equipped than the private units (Barone et al., 2014). The 
National Health Service finances the purchase of the equipment. The patients therefore 
believe that any complication that arises from the procedures would be well dealt with 
when the patient is at the public unit. The choice of the modality and center is, therefore, 
said to be influenced by the preferences of the patients and the clinical advice of the 
physicians. The preference of the modality might be influenced by the patient’s 
knowledge of dialysis modalities. Foley et al. (2014) noted that a patient’s commitments 
such as work and family influence the choice of dialysis center. Hence, the patient plays a 
great role in determination of the dialysis modality and the center. 
The urgent start of dialysis using PD for ESRD patients is feasible as compared to 
the use of hemodialysis. .As the number of patients with end-stage renal disease is on the 
rise, there is a need to adopt a strategy of minimizing the prevalence which is enhanced 
through dialysis. .According to the United States Renal Data System 2014 annual report 
data, it is estimated that there is 0.14% prevalence of patients with end-stage renal disease 
(Jin et al., 2016). Patients with ESRD do not have a distinct plan for starting dialysis 
which calls for urgent dialysis. The urgent start of dialysis using peritoneal dialysis has 
been considered by most nephrologists since it does not require functional pre-established 
vascular access. Hemodialysis used in most healthcare centers requires the high use of 
central venous catheter at the time of initiating dialysis (Jin et al., 2016). The urgent start 
of dialysis using PD can serve patients well. The urgent start of dialysis by use of 
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hemodialysis is associated with a probability of bacteremia infections as compared to 
patients starting dialysis under PD mode.  
Peritoneal Dialysis versus Hemodialysis in Adults 
Single center 
Improvement of survival rates because of timely shift of PD to HD. Studies have 
been conducted to investigate the improvements of survival rates as a result of timely 
shift of PD to HD. Panagoutsos et al. (2008) focused on patients from Greece who were 
on dialysis for 10 years in a single Division of Nephrology. The researchers determined 
five-year survival rates for 299 patients and considered factors such as gender, age, serum 
albumin, and common diseases. The researchers compared three categories of patients 
including those who were starting PD, those who were starting HD, and those who were 
changing from PD to HD. The researchers also evaluated use of serum albumin and 
dialysis dose between the groups and established that there was no significant variance. 
The study established two survival curve phases; PD is boosted by RRF in the initial 
phase while the second phase is characterized by a loss of RRF. The study also 
established an increase in the mortality risk among PD patients resulting from a decline in 
Kt/V (Panagoutsos et al., 2008). 
The use of PD has been well established all over the world as a therapy of renal 
replacement in ESRD patients. Nevertheless, there is need for timely shift from PD to HD 
for variety of reasons. These reasons include repeated infections and peritoneal 
membrane function. The shift should be timed when the patient has mature AVF 
(Panagoutsos et al., 2008).  
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There are various benefits accrued to timely shift from PD to HD. Improved 
mortality rate is the main aim for the shift to HD. Panagoutsos et al. (2008) carried out a 
research which involved patients who started their treatment during the last 10 years. 
There were 33 PD patients who ranged from 40 years to 70 years of age who transferred 
to HD, another 134 PD patients who were aged between 53 years and 75 years used only 
PD. The study also involved 132 patients aged between 32 years and 64 years of age who 
started and remained in HD. The main reasons why the patients transferred to HD were 
loss of ultrafiltration and relapsed peritonitis. The results indicated that 3-year survival 
rates for those who changed dialyses were 97%, those who started and remained in PD 
were 54%, and those who started and remained in HD were 92%. For 5-year survival 
rate, those who shifted indicated a rate of 81%, those who remained in PD indicated 28%, 
and those who remained in HD indicated a rate of 83%. These results indicated that 3-
year survival rate was significantly higher for the patients who shifted from PD to HD 
than those who remained in PD or HD. It was also evident that the 5-year survival rate 
was higher in the patients who shifted than those who remained in PD. However, there 
was no significant difference in the HD patients. It was therefore evident that the transfer 
of patients from PD to HD improved their survival after they develop PD related 
complications. However the study did not determine the optimal switching time. This 
study will aim to fill this gap.  
In addition, studies have shown that although peritoneal dialysis has many 
advantages compared to hemodialysis, the dialysis modality remains underutilized as the 
initial modality of the end-stage renal disease patients (Contreras et al., 2014). A majority 
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of patients in the United States (93%) starts dialysis through the use of HD modality 
(Ghaffari et al., 2013). A majority of ESRD patients starts dialysis using HD due to the 
ease of initiating HD, physician experience and training, lack of PD infrastructure to 
enhance successful dialysis by use of PD as well as inadequate pre-ESRD patient 
education. The PD dialysis modality has been observed to have a high survival advantage 
in the early years of dialysis initiation. The early survival advantage is independent of 
patient’s characteristics such as age as well as co-morbidities such as diabetes and 
cardiovascular diseases. The PD has shown significant improvement of mortality rates in 
the first year of dialysis whereas the HD has not shown the significant improvement since 
the 1990s (Ghaffari et al., 2013). The PD modality is associated with improved quality of 
life as well as reduced costs. Patients who switch from PD to HD have the same cost of 
dialysis as patients under HD dialysis modality only. In addition, initial dialysis through 
the use of PD is associated with management and improvement of residual renal function. 
Managed residual renal function improves patient’s survival rates (Ghaffari et al., 2013). 
Moreover, Beladi et al. (2015) indicated that there is increased patients’ survival 
advantage of PD patients during the first year of initiating dialysis. Pajek et al. (2014) 
indicated that timely switching from PD to HD due to technique failure improves 
patients’ outcomes and survival. The mortality rates of patients are decreased.  
Comparison of clinical outcomes of PD and HD in elderly patients. There is an 
increasing growth of elderly patients seeking dialysis treatment in the U.S.A. It is 
therefore important to determine the most efficient modality and the best way to 
implement either of the modalities. The dialysis, PD and HD differ in terms of quality of 
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life and particularly to the elderly who are more exposed than the younger patients 
(Aghakhani, Samadzadeh, Mafi, & Rahbar, 2012). In United States, PD is less frequently 
used in elderly patients as compared to younger patients, different studies have defined 
elderly patients differently with some of the defining it as those aged 65 and above while 
other defining it as those aged 75 and above. In 2009, the USRDS data depicted that 12% 
of the dialysis patients aged 20 to 55 were on PD while only 4% of the patients aged 75 
and above were on PD. But this different when compared with other countries like France 
where PD is dominant in elderly patients. In France more than half of the PD patients are 
aged 70 years and above. In Hong Kong, of all the patients who are on dialysis, 80% are 
on PD. In United Kingdom, 17% of the elderly patients are on PD, while in Canada; only 
12% of the elderly patients are on PD. This is a clear indication that the modality choice 
varies from one country to the other. 
The cost of the modality treatments does not seem to affect the choice of mode of 
treatment. In United States, the cost of HD is relatively higher than that of PD. The 
choice of HD against PD by the elderly patients has some financial implications. The 
wide use of HD by the elderly patients is enhanced by the resource availability and 
cultural issues (Wright, 2009). This implies that there is no significant difference in the 
outcomes of the modalities and the choice might be affected by other factors such as 
cultural issues. However, there are other factors that may be considered in choosing 
either PD or HD. 
There are challenges that are evident in using either PD or HD for elderly 
patients. Quality of life is predominantly important for the elderly patients on dialysis. 
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One factor is travel time to and from the dialysis center which can have a negative impact 
on patient’s quality of life as well as the patient’s caregiver (Joshi, 2014). The patients 
are also required to have a peritoneum that is not disrupted by prior surgeries and ability 
to perform daily medical technique. It is, therefore, important to assist the patient who 
cannot be able to perform these tasks. The main advantage of PD is that it is 
physiologically gentle and it can be performed at home. However, in comparison of 
clinical outcomes of these two modalities, it is good to consider the effect on infection 
rate. 
Younger patients have portrayed better quality of life when subjected to PD as 
compared to HD (Barone et al., 2014). For elderly patients, they portray the same quality 
of life across PD and HD. PD is appropriate for any patient who would like to dialyze at 
night and those who place a lot of value on independence (Barone, et al., 2014). Elderly 
patients therefore consider other factors except quality of life in choosing the modality 
treatment. Those who would like to dialyze at night can use PD. However, younger 
patients portray better quality of life on PD. Nutrition is another clinical outcome that 
should be considered across all the modalities in elderly patients. 
Multicenter 
Mortality between HD and PD dialysis patients. Multicenter has demonstrated 
different results as compared to single-center in respect to mortality rate of HD and PD. 
A study by Chiu et al. (2011) analyzed the mortality data from 822 consecutive patients 
starting the dialysis process in 11 centers. The study involved extensive collection of 
comorbidity data before the patient started the dialysis process with an average follow up 
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of 24 months. There was a significant difference with respect to HD and PD patient’s 
hemoglobin (Hb), age, comorbidity and albumin score. It was observed that the HD 
group had significantly higher scores. Data was also collected in relation to severity of 
disease and acuity of onset of the renal failure.  
A comparison of mortality data from both groups indicated that no disparities 
between the survival rates of the two groups. The researchers deduced that the apparent 
initial survival advantage of PD patients in previous studies could be as a result of lower 
incidence of important start in PD cohorts and lower comorbidity (Chiu et al., 2011). This 
study affirmed that the survival advantage in any of the two treatment modes was lost due 
to adjustment of comorbidities and acute start in the final phase.  
Research has indicated differences in mortality and survival rates of ESRD 
patients under PD and HD dialysis modalities. The differences are observed due to the 
different causes of ESRD, differences in age, co-morbid diseases, and the time of 
initiation of dialysis (Beladi Mousavi, Hayati, Valavi, Rekabi, & Mousavi, 2015). The 
mortality of ESRD patients varies with the presence and absence of diabetes mellitus, 
where survival is worst for patients with diabetic nephropathy. In addition, Yang et al. 
(2015) observed that mortality of ESRD patients is higher for patients undergoing 
dialysis through PD as compared to patients under HD modality.  
Effect of duration of dialysis on mortality in HD and PD dialysis. The duration 
period under which the patient undergoes the treatment affects the mortality rate of the 
patients. Yamagata et al. (2012) conducted a study involving 1222 new patients starting a 
dialysis process for over a period of four years in Japan. The study was a large, 
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prospective, observational, multicenter cohort study. The collected data focused on 
primary renal disease, RRF comorbidities, albumin, and efficacy of dialysis, the patients’ 
nourishment status, and Hb at the start of the dialysis process and at various stages during 
the 4 years study period. Subgroups were analyzed according to variables such as gender, 
diabetes, age, and cardiovascular disease (CVD). Averagely, the HD cohort had more 
comorbid conditions, was older, had poorer RRF, and lower Hb. There was no 
noteworthy disparity in serum albumin. The researchers also noted that the unadjusted 
mortality rates were considerably higher in the HD group, mainly in the initial 12 months 
after start of the dialysis process and remained comparatively static until the fourth year. 
The findings also indicated that the mortality rates among the PD group increased over 
the four years observation period. There were unsubstantial differences in the intent as 
treated or to-treat analyses. After the adjustment, the relative risk (RR) of death for HD 
was not statistically significant as compared with PD patients until one year, but showed 
a significant PD advantage. Nevertheless, an RR disadvantage was discovered with PD 
up until two years for patients with varying ages. 
For patients aged less than 60 years with no diabetes, there was no statistical 
significant discrepancy in the survival rates between HD and PD during the course of the 
study. For the younger group of patients suffering from diabetes, a significantly higher 
mortality rate among the HD patients in the period of up to two years was noted 
(Yamagata et al., 2012). Irrespective of diabetic status, gender or CVD status, the two to 
four year analysis portrayed a survival benefit in favor of HD patients for all patients 
older than 60 years. It was, therefore, concluded that the use of PD for a long-term, 
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particularly among the elderly, is related to an increment in mortality. Further studies 
were also recommended to investigate the probable survival advantage among PD 
patients who timely shift to the HD treatment modality.  
Comparison between PD and HD in relation to mortality risk in patients with 
chronic kidney disease. Chronic kidney disease affected the mortality rate of the patients 
on PD and HD. Maier et al. (2009) conducted a research study among 1,041 patients on 
PD and HD from 81 dialysis clinics. This prospective study took place for a period of 
seven (7) years. Data were gathered on disease severity and coexisting diseases along 
with sex, age, racial or ethnic background, Hb, C-reactive protein, serum albumin, BMI, 
and residual urine output. Following the calculations, there were no significant disparities 
in the mortality risk between PD and HD patients who were receiving treatment for the 
first one year. Conversely, after being on treatment for two years, the risk of mortality 
was notably greater among PD patients. Although an increased death risk with PD use for 
elderly or diabetic patients was not detected, a slightly higher risk of death among certain 
groups on PD particularly the patients who had a history of CVD. 
Registry data analysis. This section highlights some of the published registry 
data analysis done in various countries such as Netherlands, USA, Italy, Denmark, and 
Canada. 
Adjusted mortality rates between HD and PD dialysis. A register data analysis of 
the Taiwan Organ Replacement was conducted by Huang, Cheng, and Wu (2008). The 
study was done on 11,970 patients who were suffering from stage five kidney disease and 
involved a follow up of up to five years. Where deaths occurred, they were associated 
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with the treatment modalities that the patients were receiving before death (Huang et al., 
2008). Compiled data from the study and calculated for primary renal disease, age, pre-
dialysis comorbidities, and center size. The study findings indicated that the risk of 
mortality for patients starting the PD treatment was 73% compared to that of the patients 
who were commencing with HD when considering certain predictive factors; but, this 
became less evident when certain subgroups were removed from the data (particularly for 
those over the age of 65 years and with diabetes). The death rate for patients on PD 
increased over a period of time while the survival rate among HD patients formed a U 
shape. 
Mortality in end-stage renal disease. Registry data was used to analyze survival 
rate in ESRD in Canada. The data involved 204,000 incident and prevalent patients for a 
period of over 7 years. There were noteworthy disparities in the rates of mortality based 
on different aspects including age, gender, and diabetes. However, there lacked 
significant disparities in the death rates for non-diabetic HD and PD patients with regards 
to race, gender, or age. On the other hand, patients aged 50 years and above and who 
suffered from diabetes portrayed significant increase in the risk of mortality on PD and 
HD (Yeates et al., 2012). The risk was higher among females rather than males. This was 
apparently the primary noteworthy interaction of gender-by-treatment that was identified. 
A significantly lower mortality rate was recorded among patients below the age of 50 
years when the ESRD patient was treated with PD compared to HD. 
The number of patients receiving treatment as a result of end-stage renal disease 
is increasing. Patients observed to have chronic kidney disease are at high risks of dying 
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due to cardiovascular sources. The patients are faced with sudden cardiac deaths due to 
arrhythmias (Chen et al., 2014). The mortality of ESRD patients with cardiovascular 
diseases has been reduced by the use of implantable cardioverter defibrillators (ICDs). 
The ICDs also serve the role of reducing the risk of getting heart attacks. The patients 
with chronic kidney disease for both men and women have been found to have lower life 
expectancy. The life expectancy has been observed to decline for the patients with kidney 
failure (Turin et al., 2012). People with diabetes have been observed to have greatly 
reduced life expectancies. A study conducted indicated that patients with diabetes have 
eight years life expectancy less than patients that are non-diabetic (Turin et al., 2012). 
The mortality rates for patients with ESRD are thus on the rise such that the survival rate 
of patients is less than the patients with AIDs. The survival rate decreases as the patients 
ages (O’Connor & Corcoran, 2012). 
Comparison of initial survival advantage of PD against HD. The use of PD in 
United States has increased due to its low cost, convenience and simplicity. The survival 
rate and quality of life has also improved in this modality due to antibiotic prophylaxis, 
advances in technique, and the newer solutions that are available. The rate of 
complications that are associated with PD has also reduced due to these advances 
(Pranav, Harbaksh, & Kunal 2011). The achievement of adequate clearance associated 
with PD and the perception by nephrologists on better survival rates on HD has really 
influenced the choice of modality globally. Nevertheless, studies have shown that 
initiating the treatments on PD is advantageous as compared to initiating the treatment on 
HD. 
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All ESRD patients have the goal of improving the survival rate, reduce morbidity, 
preserving residual renal function and improving the quality of life. It happens that most 
of the ESRD patients will receive HD, PD and renal transplantation at a particular point 
in their lifetime. The rate of survival for the first 2 years is higher in PD than in HD 
.Other factors that compel the use of PD first are convenience of home therapy, increased 
freedom for the patient. Preservation of residual renal function is another factor that 
compels the ESRD patients to start with PD. 
Residual renal function (RRF) is a very important factor clinically because it 
contributes to quality of life, adequacy of dialysis, and mortality in dialysis patients. The 
reduction in RRF reduces middle and small molecular weight toxin clearance increase 
phosphorous, sodium and water retention and decreases erythropoietin synthesis (Wang 
& Lai, 2006). The loss consequently leads to malnutrition, anemia, cardiac hypertrophy, 
congestive Cardiovascular Disease atherosclerosis, valvular calcification, vascular and 
increase in cardiovascular mortality and morbidity. Another factor that compels the 
ESRD patients to start with PD is lower infection and hospitalization rates. Infection is 
the other major cause of death for dialysis patients. According to Aslam, Bernardini, 
Fried, Burr, and Piraino (2006), the rate of admission for septicemia/bacteremia is 1.5 to 
2.3 times higher for the HD patients as compared to PD patients. The introduction of Y 
set systems and twin bags has reduced the rate of PD peritonitis in the recent past. 
Therefore, there is reduction of the rate of infection for the PD patients as compared to 
HD patients and this compels the ESRD patients to start with PD instead of HD. Patient 
satisfaction is another factor that compels the ESRD patients to start with PD.  
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One can receive home based therapy through PD. This eliminates the need for 
going to the dialysis unit for three times a week. The PD patients commonly visit their 
physician once in every month. Due to the flexibility of PD, ESRD patients can travel 
and participate in various different activities (Wasserfallen et al., 2006). Patients on PD 
give excellent ratings of dialysis as compared to HD patients. This level of satisfaction is 
also observed across all the demographic factors such as age gender, race, education, 
marital status, distance from the center, employment factors, and time since the start of 
dialysis (Lukowsky et al., 2013). It therefore follows that the level of satisfaction for the 
PD patients is higher that of HD patients. Nevertheless, the advantage of starting with PD 
is also affected by other demographic factors such as age, gender, and sex. 
Initial response of the treatment differs along the demographic factors. According 
to the study conducted by Sens et al. (2011), the factors taken into consideration were 
sex, age, and primary renal disease. The results portrayed a substantial advantage of PD 
as compared to HD for up to 2 years of dialysis after which the results were substantially 
similar. The difference was not significant for older patients as well as those with 
diabetes, but there was no subgroup where the use of PD in treatment had a statistically 
substantial detrimental effect. When the patients were first subjected to PD, the survival 
rate was better as compared to HD. However, older patients never showed any significant 
difference. 
Comparison of survival outcomes for ESRD patients in PD and HD modalities. 
Peritoneal dialysis and Hemodialysis are widely recognized renal replacement therapies 
for end-stage renal disease patients (Liu et al., 2013). Observational studies have 
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attempted to establish the mortality rates of ESRD patients using hemodialysis and 
peritoneal dialysis. However, it is not yet clear as to which modality prolongs the survival 
rates of ESRD patients (Yang et al., 2015). Moreover, the survival rates of patients with 
cardiovascular diseases between peritoneal dialysis and hemodialysis have not yet been 
established (Liu et al., 2013). Similarly, there exist conflicting results about the mortality 
rates of ESRD patients in different studies. The conflicting findings arise due to 
differences in methodology of the studies as well as the period of follow-up (Liu et al., 
2013). However, a study conducted by Yang et al. (2015) revealed that survival outcome 
for ESRD patients for the year of treatment is not significantly different for patients under 
hemodialysis and peritoneal dialysis. In the long term, patients initiating treatment using 
peritoneal dialysis had higher mortality rates compared to patients under hemodialysis 
(Heaf & Wehberg, 2014). Moreover, young patients without cardiovascular diseases and 
diabetes mellitus perform better while under peritoneal dialysis than in hemodialysis 
(Yang et al., 2015). 
Comparison of HD and PD dialysis survival in the Netherlands. A study was 
carried out based on data from the Dutch End-Stage Renal Disease Registry (RENINE). 
The study involved 16,643 patients and was carried out for a period of 15 years. Of 
interest to the study while computing was gender, age, year of start of dialysis, center of 
dialysis, and the primary renal disease. The results verified an early survival benefit for 
PD compared with HD therapy (Liem, Wong, Hunink, Charro, & Winkelmayer, 2010). 
Nevertheless, the survival benefit diminished with age and the presence of diabetes as a 
result of renal failure. 
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Registry data studies on specific patient subgroups 
Development of cardiovascular disease through modality of treatment in 
patients suffering from end-stage kidney disease. Depending on the modality treatment, 
the development of cardiovascular disease varies. A study that involved 4,191 patients for 
a period of three years was conducted. Their aim was to look at both the risk of 
developing CVD and mortality depending on the choice of modality. Germane endpoints 
for the study included death, chronic Cardiovascular Disease or the development of 
ischemic heart disease. CVD was determined by conditions such as; myocardial 
infarction, congestive cardiac failure, and coronary artery disease. The results, when 
computed for age, established CVD, and gender, failed to indicate any significant 
disparities in the survival rates of patients undertaking PD and those on HD (Zyga & 
Kolovos, 2013). Similarly, no significant difference was witnessed in the patient number 
in either modality group that developed CVD. 
To further explore the differences on modality groups, Zyga and Kolovos (2013) 
utilized prevalence data for 107, 922 new patients for a period of two years to determine 
whether PD enhanced survival rates among patients suffering from congestive 
Cardiovascular Disease (CHF) compared to HD. CHF was determined from the patients’ 
medical evidence records and the data was combined with the USRDS transplant and 
mortality data. The researchers also computed the data different comorbidities such as 
gender, age, peripheral vascular disease, glomerular filtration rate, body mass index, and 
cancer. The study established that the comorbidities were minimized when patients 
switched modalities. On average, follow up on patients was conducted for a period of 12 
81 
 
months. The computed data of the total patient group portrayed a minimized risk of death 
among PD in comparison to HD for the initial 12 months. The study findings indicated no 
difference in survival rates between the periods of 12 to 18 months, but indicated a 
considerably increased risk of death after the 18 months period. When the data analysis 
for subgroup was performed, a substantially lower survival rate for diabetic and non-
diabetic patients with CHF was determined after six (6) months if they started with PD 
treatment modality compared to when they started with HD therapy. There was a 10% 
lower mortality risk for non-diabetic patients without CHF if they commenced with PD 
compared with HD. 
Mortality differences by dialysis modality without and with coronary artery 
disease. Mortality of patients with coronary artery disease (CAD) differs with respect to 
dialysis modality. Patients with CAD tend to have a higher risk of death. According to a 
study conducted by Wang et al. (2003) using data from US Medicare and Medicaid 
services which was merged with data from United States Renal Data System (USRDS), 
there were some significant differences in the risk of death on patients who were under 
HD or PD modality. The study revealed that patients with CAD and who commenced 
with PD had a higher relative risk of death by 23%. The patients with CAD demonstrated 
a higher risk of mortality when the mode of treatment that they were subjected to first 
was PD. However, the question of whether those patients without CAD showed any 
significant difference in mortality with respect to the modality used arises. 
Patients without CAD also demonstrated different mortality when subjected to 
different modalities. The patients demonstrated an initial survival advantage when they 
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commenced on PD for the initial six months and later an advantage in survival when on 
HD (Wang et al., 2013). It was, therefore, evident that patients with CAD had a higher a 
risk of death when commenced on PD as compared to when on HD. It was also evident 
that patients without CAD had a higher survival in long run when under HD. 
Mortality differences by dialysis modality with and without diabetes disease. The 
mortality rates of ESRD patients with diabetes are high due to poor and strict glycemic 
control of diabetes mellitus. The patients with diabetes are at high risk of dying while 
undergoing the hemodialysis mode. The chances of survival for people aged 60 years and 
below with diabetes are poor as compared to the people aged 65 years and above (Park et 
al., 2015). The number of patients with diabetes is alarming where survival rates of the 
patients are a major concern due to lack of kidney donors. In turn, the dialysis modality is 
aiding in reducing the incidences of the death outcomes. The survival rates for diabetic 
patients with ESRD are much worse than non-diabetic patients. The survival rates of 
diabetic patients with ESRD are high for patients under peritoneal dialysis than patients 
on hemodialysis (Cotovio, Rocha, & Rodrigues, 2011). The peritoneal dialysis has been 
observed to be effective in helping diabetic ESRD patients to lower their levels of ultra-
filtration. The diabetic patients under peritoneal dialysis also benefit from the 
abandonment of creating an arteriovenous fistula that fastens cardiac load thus, 
accelerating heart failure (Cotovio et al., 2011).  
Despite the wide acceptance of peritoneal dialysis in increasing survival rates for 
diabetic patients, few of the patients adopt the dialysis mode. The choice on the type of 
dialysis mode on adopting HD or PD for diabetic patients should be made on the basis of 
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medical grounds, clinical complications accrued as well as wishes of the patient. 
However, high mortality rates are accounted for ESRD patients under hemodialysis 
mode. The leading cause of mortality rate is accounted by the increase in cardiovascular 
diseases especially diabetes (Koeda, Ogawa, Ito, Tsutsui & Nitta, 2014). The diabetes 
causes the emergence of diseases such as atherosclerosis and left ventricle diastolic 
dysfunction that reduces survival rates of ESRD patients. Therefore, incidences of 
diabetes in ESRD patients under hemodialysis are high which causes an increase in 
mortality rates (Koeda et al., 2014). 
Summary of the evidence. Some studies have shown that PD mode of treatment 
is generally as equal to treatment through HD but when sub-groups such as gender, age, 
and diabetes are considered, a difference in the survival rate of the patients is observed. 
As previously indicated, (Zyga & Kolovos, 2013; Wang et al., 2013) demonstrated that 
commencement with PD is better when dealing with younger patients. The survival 
advantage however disappears after two to five years during which the patient should 
consider switching to HD. For the older patients with cardiac comorbidities or diabetes, 
there is low probability of survival when started with PD therapy (Sens et al., 2011). The 
influence of modality choice in respect to the patient characteristic is should therefore be 
considered. 
Utilization of ESRD Modalities by Patient Characteristics 
There are factors that influence the choice of treatment modality with respect to 
age, sex cause of ESRD and race. Younger patients had a higher chance of functioning 
transplants that the older counterparts (Allen et al., 2001). The results for this study were 
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as follows; 68.1% of patients under the age of 20 had functioning transplant, 48.8% of the 
ones in the age bracket of 20-44 had a functioning transplant, 31.6% of those in the 45-64 
age group had a functioning transplant and 6.8% of those aged 65 and above had a 
successful renal transplant. These results indicated a trend in functioning transplant in 
accordance to the age. Nevertheless, sex is another factor that influences the choice of 
modality for patients with ESRD. 
Sex affects the modality choice for patients with ESRD. Males have shown a 
higher possibility of having a functioning transplant as compared to females. According 
to Allen et al. (2011), males demonstrated 30.8% higher chance of having a successful 
and functioning transplant as compared to 24.8% in females. This is a clear indication 
that for the patients with ESRD, males had a better chance of having a successful 
transplant. Another cause of influence that is of interest is the cause of ESRD. 
The cause of ESRD also showed some differences in the choice of modality. 
Allen et al. (2011) confirmed that patients with cystic kidney and glomerulonephritis had 
a higher chance of having a successful and functional transplant as compared to prevalent 
patients with diabetes or hypertension. Allen et al. (2011) also pointed that these 
variations across disease categories in the choice of modality may also be influenced by 
the age or gender. With patients showing some significant difference across age, sex, and 
cause of ESRD, it is important to have in mind these effects before choosing the 
treatment modality. Hallan et al. (2012) evaluated the possible effect modification 
(interaction) by age of the association of eGFR and albuminuria with clinical risk. The 
meta-analysis included 2, 051, 244 participants from 33 general population or high-risk 
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(of vascular disease) cohorts and 13 CKD cohorts from Asia, Australasia, Europe, and 
North/South America, conducted in 1972-2011 with a mean follow-up time of 5.8 years 
(range, 0-31 years). The conclusion was that both low eGFR and high albuminuria were 
independently associated with mortality and ESRD regardless of age across a wide range 
of populations. 
Impact of Combining PD and HD Therapy on Peritoneal Function 
There are various effects of combining PD and HD on Peritoneal Function. The 
main advantages of peritoneal dialysis (PD) are continuous correction of acid–base 
equilibrium and retention of residual renal function (RRF). However, after RRF is lost, 
increase in the PD dose is limited; this results in possible inducement of uremic state and 
insufficient solute clearance. For such cases, the addition of hemodialysis (HD) to PD 
increases the ultrafiltration volume and dialysis dose, thereby optimizing dialysis. 
Agarwal, Clinard, and Burkart (2003) reported that the combination of HD and PD 
improved an ultrafiltration failure and insufficient dialysis dose. According to Moriishi et 
al. (2010), switching to PD 5 to 6 days per week, from PD 7 days per week combined 
with HD once per week, improves nutrition status, and increases the dialysis dose. 
Moriishi et al. (2010) reported that a combination of both PD and HD is a simple and 
reliable method for increasing the dose of dialysis after RRF loss. Nevertheless, the 
combination procedure should be keenly followed in terms of the number of times that it 
should be administered per week. 
In combination therapy of PD and HD, HD is performed 1 to 2 times per week, 
which implies there is a period through which no dialysis solution is reserved in the 
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abdominal cavity. On top of that, the ultrafiltration volume is mainly controlled by HD, 
which in turn reduces the need to use the solution for high-glucose dialysis thus lowering 
the glucose load. These advantages have been suggested to influence peritoneal function. 
RRF is a vital prognostic factor in PD patients. However, RRF is lost in duration of 
several years, the solute clearance becomes inadequate, and extra body fluid mounts up in 
such patients. Matsuo et al.(2010) showed that an increase in the clearance of low 
molecular weight solutes failed to improve prognosis. Frequent use of hypertonic solution 
and increase in the volume of dialysis solution did not improve survival; instead, these 
techniques enhanced the impairment of peritoneal function and accelerated the 
occurrence of encapsulating peritoneal sclerosis (EPS). 
A study that involved 76 patients for a period of 12 years was carried out to 
investigate the effect of the combination. A peritoneal equilibrium test (PET) was 
performed at the beginning of a combination of PD and HD therapy and this test was 
used to group patients into four, based on the dialysate to plasma ratio of creatinine (D/P 
Cr). The groups were; 
• High (H=5) 
• High average (HA=29) 
• Low average (LA=26) 
• Low (L=16) 
The D/P remained high in the H group but declined significantly in the HA group 
and appeared to decline in the LA and L groups. The eFDP level decreased noticeably 
after initiation of a combination of PD and HD therapy in H group, although the change 
87 
 
was not significant. According to Moriishi et al. (2010), therapy with PD and HD led to 
retention of peritoneal function in patients who had lost RRF and aided continuation of 
PD. Nevertheless, peritoneal function failed to improve in patients with already 
deteriorated function. A therapeutic method change should thus be considered for such 
patients.  
National Dialysis Center 
National Dialysis Center is an international health care group that operates more 
than 3,250 dialysis centers around the world and bases its dialysis treatment on high 
quality standards (National Dialysis Center, 2015a).Hemodialysis, acute dialysis, 
peritoneal dialysis, dialysis care, spectra laboratories, liver support therapy, and 
therapeutical apheresis among other services. Most patients undergo hemodialysis out-
patient treatment at one of approximately 28,000 dialysis centers around the world. The 
organization uses clinical databases to improve integrated quality management which 
also support nephrologists while taking care of patients. The corporation collects 
treatment information from dialysis patients in databases, allowing comparisons of 
treatment quality between dialysis centers. 
Summary and Conclusions 
The literature review shows that dialysis modes HD and PD have varied outcome 
that is affected by socio demographic factors such as age, gender and education level and 
presence of other diseases. One of these outcomes is technique failure which can be 
indicated by loss of renal function in PD patients necessitating a switch to HD. It is 
known that outcome is affected by other factors but knowledge in of the role of factors in 
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preserving renal function and technique success and failure is limited. The studies in this 
aspect used  a small sample size of not more than 1300 but this study will fill this gap by 
using a large sample size drawn from a national population. This chapter has showed 
what is known and the gap that this study will seek to fill. The following chapter (chapter 
three) gives an in depth description of how the researcher will conduct the research in 
order to fill the gap identified. The research methodology and design will be discussed. 
The population and sample will also be included in the discussion. Moreover, the data 
collection procedure and data analysis will be presented. 
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Chapter 3: Research Method 
Introduction 
The main objective of the study was to examine the optimal timing of the switch 
from PD to HD in maintaining renal function and the impact of demographic factors (age, 
gender) and comorbidities (diabetes, CVD). In this study, optimal timing was defined as 
the period within the first 6 months when switching from PD to HD improves ESRD 
patient outcomes as demonstrated by an improvement in the patients’ RRF, indicated by 
GFR. The optimal switching time was calculated as an average of the time taken for 
patients who switched to demonstrate an improvement in RRF as indicated by the GFR. 
The research methodology chapter highlights the actions that were taken in order to test 
the study hypotheses and answer the research questions. The chapter highlights the study 
population,  the sampling criteria, and data collection method that were adopted after 
application of power analysis to address the research questions and the hypotheses. This 
is followed by the data analysis plan which includes descriptive statistics to give 
meaningful summaries and inferential statistics to explore the relationships between the 
variables. I have identified and outlined the threats to validity taking into consideration 
the threats to internal and external validity. The last section of the chapter outlines the 
ethical considerations that were observed during the study. 
Research Design and Rationale 
In line with the study objectives and hypotheses, renal function and optimal 
dialysis for switching are the dependent variables while PD, HD, switching from PD to 
HD, social demographic factors (age, gender), and diseases (diabetes and CVD) are 
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independent variables. The diseases are assessed based on their presence or absence in 
ESRD patients. Creswell (2003) advised researchers to adopt research designs that enable 
them to collect and analyze data and clearly answer their research questions. In this 
regard, the best research design is one that most easily facilitates the collection of 
appropriate data and aligns with the research questions. The other factors that should be 
taken into consideration when determining the research design to adopt include time and 
accessibility of resources (Creswell, 2003; Johnson & Christensen, 2008).  
A quantitative research design is the collection and manipulation of numerical 
data with an aim of meaningfully describing the phenomenon that the data represented 
(Creswell, 2003). A quantitative research design is appropriate when the researcher 
intends to extract summaries from the data (Johnson & Christensen, 2008). I chose a 
quantitative design in order to support the research hypotheses and the preconceived 
relationship between the variables in the study. This aligns with a study by Johnson and 
Christensen (2008) who observed that if a researcher intends to statistically test 
hypotheses that explore relationship between two or more variables, a quantitative design 
is most appropriate. The three dialysis modes, social factors, and other diseases exhibit 
relationships which were best explored by a quantitative design. Specifically, I  adopted a 
cohort study design which allowed for evaluation of the ESRD patient clinical indices 
based on the data from the records of National Dialysis Center. National Dialysis Center 
was selected since it is known worldwide for providing dialysis services for persons with 
chronic kidney failure (National Dialysis Center, 2015a). The National Dialysis Center 
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database holds large amount of kidney dialysis records with over 290, 250 patients 
receiving 43 million treatments to date. 
Methodology 
Population 
A study population refers to the total number of the study subjects (Lu & Gatua, 
2014). The population in this study consisted of over 128, 000 ESRD patients across the 
U.S. who received treatment from National Dialysis Center. This included  patients from 
all ethnicities, ages, and gender from 2005 to 2015. Only ESRD patients with CVD and 
diabetes were part of the target population. 
Sampling and sampling procedures 
Sampling technique. It is not possible for researchers to study entire populations 
due to time and resource constraints. This leads to selection of samples from the 
population. Researchers use two key sampling techniques probability and nonprobability 
sampling (Onwuegbuzie, Slate, Leech, & Collins, 2009). Probability sampling creates a 
likelihood of every subject in the population being selected to be part of the study sample 
(Grafstrom & Lundstrom, 2013). This study adopted probability sampling; the study 
captured data of patients who have undergone three dialyses modes with other factors 
like diabetes and cardiovascular diseases. 
When a researcher is interested in studying the characteristics of subpopulations, 
the stratified random sampling should be used as a sampling technique to ensure all the 
subpopulations are captured in the final dataset (Khan, Ali, Raghav, & Bari, 2012). 
Stratified random sampling is applicable when clusters of population members exhibit 
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variation but have very similar traits within the clusters (Khan et al., 2012). Patients 
within the three dialysis modes are bound to exhibit unique characteristics of the dialysis 
mode. Stratified random sampling involves dividing the population into different 
homogenous strata then randomly selecting the desired sample size (Diaz-García & 
Ramos-Quiroga, 2014). In applying stratified random sampling in this study, the 
population was divided into homogenous strata of the three dialysis modes (PD, HD, and 
PD to HD) and then the required sample size was randomly drawn from each stratum. 
Sampling frame. How well a population is represented by a sample depends on 
the sample size, selection procedures, and the sample frame (Diaz-García & Ramos-
Quiroga, 2014). A sample frame is the proportion of the population who has the 
probability of being included in the sample by possessing the desired attributes (Diaz-
García & Ramos-Quiroga, 2014). The sampling frame must include traits that are in the 
population (Diaz-García & Ramos-Quiroga, 2014). In line with the research objectives, 
my study sampled included ESRD patients who began treatment in the USA. Only 
patients who had undergone dialysis with the treatment methods of HD, PD, and a switch 
from HD to PD were included. In line with the objective of testing the effect of presence 
of other diseases, the study sample included patients with CVD and those with diabetes. 
In addition, in order to meet the selection criteria the dialysis patients had to be 20 years 
of age or older. The selection criteria were developed to help identify as precise sample 
size and minimize possible sampling error. Table 1 demonstrates the sampling frame. 
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Table 1  
Sampling frame 
PD HD PD and HD 
List of patients aged 20 
years and above 
List of patients aged 20 
years and above 
List of patients aged 20 
years and above 
List of patients who have 
undergone dialysis 
List of patients who have 
undergone dialysis 
List of patients who have 
undergone dialysis 
List of ESRD patients List of ESRD patients List of ESRD patients 
List of patients who 
began treatment in USA 
List of patients who began 
treatment in USA 
List of patients who 
began treatment in USA 
List of patients with 
cardiovascular and 
diabetes disease 
List of patients with 
cardiovascular and diabetes 
disease 
List of patients with 
cardiovascular and 
diabetes disease 
 
Sample size. The sample size adopted for any study should enable the researcher 
to collect sufficient data that can answer the research questions (Lu & Gatua, 2014). The 
alpha level, effect size, and power of the test affect the sample size (Park, 2008). 
Additionally, the adopted sample size is influenced by constraints in time and resources. 
The power level is the probability of rejecting the null hypothesis when the alternative 
hypothesis is true (Park, 2008). A higher power level increases the probability of making 
the correct conclusion and as such in this study (Park, 2008); the power level was 0.9 in 
hypothesis testing for my study. A large power of the test indicates a higher probability of 
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rejecting the null hypothesis (Park, 2008). In quantitative design it is essential to outline 
the hypothesis testing procedure which includes rejection-acceptance standards by setting 
the alpha level (Figueiredo Filho et al., 2013). This is achieved by setting the alpha level. 
A smaller alpha level increases the chances of detecting any significance, but a very 
small alpha level will be stringent and require a large sample size to detect an effect 
(Figueiredo Filho et al., 2013). Effect size is a measure of the magnitude of a treatment 
effect which is established by quantifying the sizes of differences or the sizes of 
associations (Figueiredo Filho et al., 2013). The study utilized an alpha level of 0.05. 
Hagen, Lafranca, IJzermans, and Frank (2014) used an effect size of 0.04 for cohort and 
experimental studies while Ferguson (2009) recommended a small effect size for studies 
seeking to evaluate the effectiveness of an intervention. I chose an effect size of 0.038 for 
my study. Cunningham and McCrum-Gardner (2007) indicated that there is no set 
criterion for choosing the effect size and thus, it is influenced by researcher’s decision. In 
power analysis, the sample size is determined as a function of the three variables: the 
power, alpha level, and the effect size (Gelman & Carlin, 2014). G*Power was used to 
obtain the minimum sample to be used (McCrum-Gardner, 2014). With an alpha level of 
0.05, power of 0.9, and effect size of 0.038, the total sample size of my study was30,000, 
which were distributed in the three dialysis modes. I used a database with 128,000 
patients. The number of cases with renal failure was achieved through employing 
keyword renal failure within the search engine of medical databases following the 
sampling frame criterion and within the specified time frame since the National Dialysis 
Center has treated over 290,250 patients with kidney failure. The National Dialysis 
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Center is a worldwide center for addressing chronic kidney diseases such as kidney 
failure or renal failure (National Dialysis Center, 2015). I sought to use at least 30,000 
records but opted to use as many patient records as retrieved. This increased validity of 
the findings.  
Procedure for Data Collection 
Data collection entails assembling the data that are used to answer the research 
questions. There are two types of data: primary and secondary (Cresswell, 2009). Primary 
data is first-hand information that is sourced from the study subjects while secondary data 
is sourced from printed materials (Cresswell, 2009). This study was based on secondary 
data that was sourced from the records of National Dialysis Center. Permission was 
obtained from the management of National Dialysis Center in order to allow the 
researcher access the patients’ records. The permission was requested through the use of 
permission letter. A memorandum of understanding and data use agreement was obtained 
from the authorities from the medical center regarding the intended outcomes, study 
subjects, and the aim for which data was and was not be used. The Institution Review 
Board in my university assessed the validity of the memorandum of understanding and 
data use agreement documents. 
Data cleaning and screening. Data cleaning entails checking for inconsistencies, 
errors,  omissions, and the presence of outliers while taking the necessary steps to 
standardize the data (Maccio, Chiang, & Down, 2014). Testing for normality followed 
data cleaning (Mickey, Dunn, & Clark, 2004). Data cleaning also involved validation 
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checks in order to ensure that ethical considerations for data privacy were maintained 
during the data analysis.  
Data cleaning starts by outlining the possible inaccuracies, the methods to 
determine the errors, and how to correct the errors (Taneja, Ashri, Gupta, & Sharma, 
2014). In this study, I paid attention to different types of errors such as improperly 
spelled names of variables, null characters, outliers, inaccurate figures, and missing 
variables. Determining the erroneous values involved verifying the transposition of key 
values and checking for typographical mistakes and incorrectly entered data. The fields 
with more than one variable were also corrected accordingly. Verification of 
inconsistencies in the data were rectified by using descriptive statistics by determining 
the minimum, maximum, sum, and frequencies for the variables. I also utilized measures 
of central tendency such as standard deviation, mean, range, and mode. In the case of 
continuous variables, like age, scatter plots were used to check of outliers. 
Data Analysis Plan 
This section highlights in detail how the data was analyzed to obtain answers to 
the research questions. The section begins by outlining the research questions and 
hypotheses to be used in analysis. Statistical tests that were performed to analyze the data 
in line with the study questions and hypotheses are clearly outlined. Statistical Package 
for Social Scientists (SPSS) version 21 was used to analyze the data. The procedure for 
data collection and the procedure for data screening and cleaning which give credibility 
to the results are also listed in the section. 
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Research questions. This study focused on examining whether the timing of the 
switch from PD to HD impacts renal functions and survival times, including if 
demographic factors such as age and gender and co-morbidities such as diabetes and 
cardiovascular disease also impact both renal function and survival times for ESRD 
patients. The renal function was assessed using the GFR and RRF, whereas data for 
survival times was collected from the National Dialysis Center. 
This study was guided by the following research questions: 
RQ1: Is the dialysis time for switching from PD to HD for ESRD Patients associated 
with improved renal function and survival times, when controlling for demographic and 
comorbidity patient factors? 
RQ2: Do comorbidities modify the dialysis time for switching from PD to HD for 
ESRD Patients associated with improved renal function and survival times, when 
controlling for demographic patient factors? 
RQ3: Do demographic patient factors modify the dialysis time for switching from PD 
to HD for ESRD Patients associated with improved renal function and survival times, 
when controlling for comorbidity patient factors? 
Research Hypotheses 
Hypotheses 
H01: The timing of the switch from PD to HD does not impact renal function and 
survival times when controlling for demographic and patient factors. 
Ha1: The timing of the switch from PD to HD impacts renal function and survival 
times. 
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H02: Comorbidities do not impact the dialysis time of switching from PD to HD when 
controlling for demographic patient factors. 
Ha2: Comorbidities impact the dialysis time of switching from PD to HD when 
controlling for demographic patient factors 
H03: Demographic factors do not impact the dialysis time of switching from PD to 
HD when controlling for comorbidity patient factors. 
Ha3: Demographic factors impact the dialysis time of switching from PD to HD when 
controlling for comorbidity patient factors? 
Statistical Tests 
Descriptive statistics. Descriptive statistics is the meaningful description of data 
by use of a few indices (Shang, 2015). If the indices are of the entire population then they 
are called parameters whereas if they are of a sample they are called statistics. In this line, 
the researcher used statistics. Measures of central tendency and the measures of 
variability are the descriptive statistics the researcher utilized. The researcher 
summarized the data by use of measures of central tendency such as mean, mode, 
maximum, minimum and range (Shang, 2015). Measures of variability such as variance 
showed how the data was spread. Further, the researcher graphed the data. 
Chi square test of independence. The study hypotheses are aimed at detecting the 
existence of relationship between the variables. Chi-square test is used to determine the 
association between two categorical variables (Agnese et al., 2012). Chi-square tests the 
hypothesis of no association between two or more factors or criterion. The decision 
criterion of establishing existence of a relationship was comparing the P value 
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corresponding to the chi-square statistic and the level of significance for the study. If the 
P value is less than the level of significance the null hypothesis of association is rejected 
and alternate hypothesis accepted but if the P value is less than the level of significance, 
the null hypothesis fails to be rejected (Bacciu, Etchells, Lisboa, & Whittaker, 2013). 
The Chi-square test was used to answer research questions two and three. In this 
study, the researcher explored the relationship between social factors (age and gender) 
and co-morbidities (diabetes and CVD) with the optimal dialysis time for switching from 
PD to HD for ESRD patients. The researcher expects to find that social demographic 
factors and medical conditions are associated with the optimal dialysis time for switching 
from PD to HD for ESRD Patients. 
Kaplan-Meier Survival Curves and the Log-Rank Test. The Kaplan-Meier 
Survival Curves is used to analyze time taken before the occurrence of an event and the 
number of research objects or participants who are involved in the event (Jelkic, Opacak, 
Horvat, & Safner, 2013). In medical research, the Kaplan–Meier Survival Curves are 
used to measure the fraction of patients living for a certain amount of time after treatment 
(Foerster et al., 2014). The Kaplan–Meier estimator was used to evaluate the number of 
patients who survived after switching from PD to HD compared to those with and 
without diabetes and cardiovascular diseases and those in different age brackets as well 
as gender. 
The different groups of patients produced varied Kaplan–Meier estimators. It is 
informative to compare the estimators to establish any variations or similarities across the 
groups after switching from PD to HD. This was achieved by using the Log-Rank Test 
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which is used to compare the survival distributions of two or more groups (Wu, 2014). 
As such, the survival rate across patients with and without diabetes and those with and 
without CVD were compared to establish the modifying effect of the variables on a 
patient’s survival.  
Cochran Mantel Haenszel. The study hypotheses seek to establish the existence 
of relationships between dialysis modes and improved renal function and the effect of 
social factors and existence of other diseases on technique failure. The relationship might 
depend on another factor. It was the interest to me to establish the nature of the 
relationship upon including a third factor. For instance, I explored if the effect of diabetes 
and cardio vascular diseases on improved RRF was similar across gender or age. Hagen, 
et al. (2014) and Kathleen et al. (2006) used Cochran Mantel Haenszel to explore 
relationships in their dialysis studies. The Cochran Mantel Haenszel is the test of 
conditional dependence with a null hypothesis that two variables are independent over a 
third factor (Yu & Gastwirth, 2008). If the P value corresponding to the chi-square 
statistic of  Cochran Mantel Haenszel is less than the α-level of significance, then the null 
hypothesis is rejected but if the P value of the chi-square statistic of Cochran Mantel 
Haenszel is greater than the α-level of significance then the null hypothesis is accepted 
(Yu & Gastwirth, 2008). 
As a result, the Cochran Mantel Haenszel was used to test the hypotheses 3 and 4 
in this study. I explored the nature of association between cardiovascular diseases and 
diabetes, and improved renal function and survival rate across gender and age as well as 
the optimal dialysis time for switching from PD to HD for ESRD patients. The analysis 
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helped to establish if the relationship is uniform for the male and female gender and its 
nature across different age groups. I expected to find that the relationship varies across 
gender and age.  
Cox-proportional hazards regressions. To explore the effect of co-morbidities on 
patient’s survival and wellbeing after undergoing switch from PD to HD, Cox-
proportional hazards regressions were used. A Cox model is a statistical technique for 
analyzing the association between the survival of a patient and a number of explanatory 
variables (Jackson et al., 2014). The regression approach evaluates the time one began a 
medical procedure and a following event such as measure of GFR and death. The model 
also offers an approximation of the treatment effect on survival after adjusting for other 
explanatory variables (Borucka, 2014). The explanatory variables to be adjusted for were 
co-morbidities and demographic factors.  
The final model from a Cox regression analysis yields an equation for the hazard 
as a model of the explanatory variables. In the model, a positive regression coefficient for 
an explanatory variable implies that the hazard is higher, and thus, the diagnosis worse 
(Zhao et al., 2014). On the contrary, a negative regression coefficient shows that there is 
a better diagnosis for patients with higher tenets of that variable. 
Threats to Validity 
Validity refers to the truthfulness of research findings. Researchers are urged to 
ensure internal and external validity (Creswell, 2009). Threats to internal validity 
influence the ability to establish causal relationships between the study variables (Morgan 
& Gliner, 2009). One of the possible threats to internal validity in this study is maturation 
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(Krauth, 2011). However, the study groups have the same maturity rate. The accuracy in 
measuring the dependent variable may also influence internal validity by introducing 
skewness towards the mean (Hyett, Kenny, & Dickson-Swift, 2014). I mitigated this 
threat by cross-checking and ensuring that the dependent variables are measured 
accordingly. The next key threat to internal validity that may influence the study is 
selection which is caused by the adopted sampling technique (Krauth, 2011). Stratified 
random sampling was used to overcome the threat of selection. In this regard, all the 
subjects had an equal chance of being in the comparison groups. Experimental mortality 
also influences the internal validity (Morgan & Gliner, 2009). Experimental mortality 
occurs where some participants discontinue participating in the study (Krauth, 2011). 
This study was not affected by this threat because the researcher used archival data which 
was already recorded prior to the study.  
Validity refers to the extent to which the research findings are generalizable to 
other contexts (Morgan & Gliner, 2009). Threats to external validity include population 
and ecological validity (Krauth, 2011). I adoptedstratified random sampling was adopted 
to mitigate the threat of population validity. This ensured that the sample was 
representative of the study population. Additionally, the sample was drawn from 
participants of different age groups. Ecological validity is also an aspect of the external 
validity and refers to the generalizability of research findings to other settings (Hyett et 
al., 2014). The threat of ecological validity could affect this study since studies in other 
settings, i.e. countries, have established different findings.  
103 
 
Ethical procedures. There are different ethical principles that should be followed 
in research studies particularly studies that engage human subjects. The ethical principles 
are applied in different stages of the research process. These principles include the 
participants’ right to privacy and right to informed consent. In this regard, I obtained 
permission from relevant authorities to conduct the study (Howard et al., 2010). The 
anonymity of the original participants was upheld by the researcher. The data was de-
identified to protect the patients’ privacy and confidentiality against revealing 
demographic information. I also adopted and upheld the non-plagiarism policy by 
ensuring that any content drawn from other studies is well acknowledged through proper 
in-text citations and proper references. I maintained objectivity in reporting the findings 
of the study without biasness. 
Summary 
The purpose of the study is to examine the efficacy of PD alone, HD alone, 
switching from PD to HD as well as establish whether social factors (age and gender) and 
medical conditions (diabetes and CVD) pay a role in ESRD technique failure. 
Information for this study was gathered from morbidity and mortality wave which can be 
measured quantitatively from ESRD patient’s records in health institutions. The 
covariates in the study were social, physical, and biological factors. These included 
geographical locations, gender, age, medical conditions, marital status, and race. 
Secondary data was used in this study. Data was collected from National Dialysis 
Center where permission was requested from the relevant authorities in charge of the 
records via the use of a permission letter and memorandum of understanding and data use 
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agreement. The study target population was ESRD patients in the National Dialysis 
Center where stratified random sampling was used to select a total sample of 30,000. 
Only patients who had undergone dialysis as mode of ESRD treatment and began 
treatment in the US was included. Further patients with cardiovascular diseases and 
diabetes were part of the sample frame. R software was used in data analysis.  
The data was screened and cleaned where omissions, incorrect entries, outliers, 
and spelling errors were checked. In data analysis, descriptive statistics were used to 
summarize the data and chi-square test of independence was used to test associations. 
Relative risk was used to examine probability of occurrences across different groups 
while Cochran Mantel Haenszel was used to test the relationship between two variables 
upon inclusion of their factor. There are various factors that affected the internal and 
external validity. In this study, the internal validity was threatened by maturation, 
measurement of dependent variable, selection of the subjects, and experimental mortality. 
However, there were various measures that were taken into consideration to reduce the 
threats such as the use of stratified random sampling. The external validity was 
threatened by some of the factors such as population sample and ecological validity. 
Nevertheless, population sample was addressed by ensuring that the sample was 
representative enough of the whole population. I considered and upheld certain ethical 
procedures. Participants’ confidentiality was observed during the study. Material and 
content that was borrowed from the works of other researchers was paraphrased, cited, 
and referenced appropriately. 
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Chapter 4: Results  
Introduction 
The purpose of this quantitative retrospective study was to examine whether the 
timing of the switch from PD to HD is more effective in maintaining renal function than 
PD or HD alone, including whether demographic factors (age, gender) and comorbidities 
(diabetes, CVD) significantly improve renal function and survival times for ESRD 
patients. In the study, I explored the independent and multivariate socio-demographic 
(age and gender) and comorbidities determinants that are associated with improved renal 
function with switching from PD to HD for ESRD patients on dialysis. The socio-
demographic examined were age and gender while comorbidities were medical 
conditions (diabetes and CVD). The Chi-square test of independence was used to show 
the relationship between cardiovascular disease, diabetes, and demographic factors and 
optimal dialysis time for switching from PD to HD. The Mantel Haenszel test was used to 
estimate whether demographic factors or comorbidity factors are independent over ESRD 
patients’ survival times while cox-proportional hazard regressions were used to analyze 
the association between the survival of a patient and a number of explanatory variables 
(age, gender, cardiovascular, and diabetes). 
The study was guided by the following research questions and hypotheses.  
RQ1: Is the dialysis time for switching from PD to HD for ESRD Patients associated 
with improved renal function and survival times, when controlling for demographic and 
comorbidity patient factors? 
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RQ2: Do comorbidities modify the dialysis time for switching from PD to HD for 
ESRD Patients associated with improved renal function and survival times, when 
controlling for demographic patient factors? 
RQ3: Do demographic patient factors modify the dialysis time for switching from PD 
to HD for ESRD Patients associated with improved renal function and survival times, 
when controlling for comorbidity patient factors? 
Research Hypotheses 
Hypotheses 
H01: The timing of the switch from PD to HD does not impact renal function and 
survival times when controlling for demographic and patient factors. 
Ha1: The timing of the switch from PD to HD impacts renal function and survival 
times. 
H02: Comorbidities do not impact the dialysis time of switching from PD to HD when 
controlling for demographic patient factors. 
Ha2: Comorbidities impact the dialysis time of switching from PD to HD when 
controlling for demographic patient factors 
H03: Demographic factors do not impact the dialysis time of switching from PD to 
HD when controlling for comorbidity patient factors. 
Ha3: Demographic factors impact the dialysis time of switching from PD to HD when 
controlling for comorbidity patient factors? 
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Data Collection 
The data was obtained from a database of more than 128,000 ESRD dialysis 
patients from National Dialysis Center. Out of these patients, a sample of 30,000 patients 
randomly distributed over three dialysis modes (PD, HD, PD to HD) was used. The PD 
represents the sample of patients who initiated dialysis and completed the study period 
under PD mode. The HD represented the sample of patients initiating dialysis and 
completed the study while on HD mode. PD to HD represented the number of patients 
who enrolled in the study by initiating dialysis using PD and switched to HD mode after 
undergoing treatment for a mean duration of 46 months through the PD dialysis. The 
sample size of 30,000 patients was obtained by use of stratified random sampling. The 
sampling frame for the study included patients who begun treatment and dialysis in the 
USA, list of patients aged 20 years and above, patients with ESRD, and patients with 
cardiovascular and diabetes diseases. The sampling frame contributed to obtaining a 
sample of 30,000 patients out of 128,000 files from the National Dialysis Center 
Database. The software used for the data analysis was R, which is statistical software for 
analyzing complex data (Kelley, Lai, & Wu, 2008). The main objective was to examine 
optimal switching times for PD to HD patients that will best preserve residual renal 
function. Also, the impact of demographic factors and comorbidities on ESRD patients 
was examined. 
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Study Results 
Descriptive Statistics 
 This section represents the demographics of the study population. In order to 
determine the optimal switching times for PD-HD patients and compare their 
performance with PD only and HD only patients, it was important to determine the social 
demographic factors and comorbidities across the dialysis mode. Table 2 presents the 
demographic and social factors across the dialysis modes. 
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Table 2  
Number of Patients’ across demographic and social factors by dialysis modes. 
 
Dialysis mode 
Total HD PD HD-PD 
Race 
White 7128 (23.76%) 7029 (23.43%) 
7103 (23.68%) 21260 
(70.87%) 
African-American 2003 (6.68%) 2139 (7.13%) 
20147 (6.82%) 24289 
(20.63%) 
Hispanic 651 (2.17%) 654 (2.18%) 
642 (2.14%) 1947 
(6.49%) 
Other 218 (0.72%) 178 (0.59%) 
208 (0.69%) 604 
(2.01%) 
Education level 
High School 1039 (3.46%) 984 (3.28%) 1019 (3.40%) 2132 
(10.14%) 
Diploma 1252 (4.17%) 1299 (4.33%) 1186 (3.95%) 3737 
(12.45%) 
Degree 7443 (24.81%) 7511 (25.04%) 7572 (25.24%) 22526 
(75.09%) 
Masters 180 (0.60%) 124 (0.41%) 152 (0.50%) 456 
(1.52%) 
Doctorate 86 (0.29%) 82 (0.27%) 71 (0.24%) 239 
(0.8%) 
Technical failure 
Peritonitis 825 (2.75%) 8792 (29.31%) 4703 (15.68%) 14320 
(47.73%) 
Acute Myocardial Infarction 405 (1.35%) 421 (1.40%) 374 (1.25%) 1200 
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(4.0%) 
Cerebrovascular disease 180 (0.60%) 213 (0.71%) 207 (0.69%) 600 
(2.0%) 
Withdrawal from dialysis 8590 (28.63%) 574 (1.91%) 4716 (15.72%) 13880 
(46.27%) 
Gender 
Males 4242 (14.14%) 4239 (14.3%) 4249 (14.16%) 12730 
(42.60%) 
Females 5758 (19.19%) 5711 (19.04%) 5751 (19.17%) 17220 
(57.40%) 
Diabetes type 
Diabetes with renal 
manifestations 
9788 (32.63%) 9808 (32.69%) 1804 (6.01%) 21400 
(71.33%) 
Diabetes Mellitus with 
chronic kidney disease 
107 (0.36%) 93 (0.31%) 100 (0.33%) 300 
(1.0%) 
No diabetes 105 (0.35%) 99 (0.33%) 8096 (26.98%) 8300 
(27.67%) 
Cardiovascular disease type 
Hypertensive Chronic kidney 
Disease 
9620 (32.07%) 9580 (31.93%) 9600 (32.00%) 28800 
(96.0%) 
No Hypertensive Chronic 
Disease 
380 (1.27%) 420 (1.40%) 400 (1.33%) 1200 
(4.0%) 
State 
Alive 9170 (30.57%) 9138 (30.46%) 
9167 (30.56%) 27475 
(91.58%) 
Dead 830 (2.77%) 862 (2.87%) 
833 (2.78%) 2525 
(8.42%) 
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 The total number of patients in the stratified sample was 30,000. The stratified 
sample has equal number of patients for each stratum. The strata included the three 
dialysis modes, PD, HD and the PD-HD. There were 10,000 patients in each of the 
dialysis modes. The highest percentage of patients in the sample was Caucasian/Non-
Hispanic (70.87%). It was followed by African-American (20.63%), Hispanic (6.49%), 
and other races (2.10%). The percentages for the races varied greatly from each other but 
all the races were evenly distributed across the dialysis modes as illustrated in Table 2. 
Most of the patients were university graduates (75%) while the least number of patients 
were those with a doctorate degree (0.8%) as shown on Table 2. The patients were also 
evenly distributed across the dialysis modes by education level. An analysis was also 
done of the patient’s technique failures across all the three dialysis modes. The results 
showed that the main causes of technique failures were PD which contributed to 48% of 
failures and withdrawal from dialysis with 46 %. The acute myocardial infarction and 
cerebrovascular disease had little effect on patients’ failure with 4% and 2% respectively. 
The sample had more female patients with a percentage of 57% compared to their male 
counterparts with a percentage of 43%. Both males and female patients were equally 
distributed across the dialysis modes as shown in Table 2 with the males and females in 
each dialysis mode constituting around 14% and 19% respectively in each mode. 
Examining the comorbidities of patients in each dialysis mode revealed that 71% of the 
patients had diabetes with renal manifestation, 1% of the patients had diabetes with 
chronic kidney disease, and 27% had no diabetes. Most of the patients with diabetes with 
renal manifestation initiated and completed dialysis using PD alone or HD alone mode. 
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Most of the patients without diabetes initiated dialysis using PD and then switched to HD 
later. On the basis of cardiovascular diseases, 96% of the patients had hypertensive 
chronic kidney disease. The patients were evenly distributed across the dialysis modes 
with regard to cardiovascular diseases. Out of the 30,000 patients in the sample, only 
8.42% of them died during the study. Among those who died, 2.77% were HD patients, 
2.87% were PD patients, and 2.78% were HD-PD patients. More than 90% of the patients 
in the sample are still alive. Both groups of patients were evenly distributed across the 
dialysis modes as shown on Table 3. 
Table 3 
Patients’ age statistics across dialysis modes 
Dialysis 
Mode 
Statistic 
Mean Median Min Max Range Sd 
PD 62.2 63 42 83 41 11.25 
HD 62.13 63 42 83 41 11.34 
PD-HD 62.72 64 21 91 70 11.91 
 
 The patients had a mean age of 62 years for each dialysis mode. PD-HD 
patients had a wider range in terms of their ages, 70 years, in contrast to that of PD 
patients and HD patients who both had a range of 41 years. The variation of the ages is 
similar, from 11.25 to 11.91, across the dialysis modes. The youngest ESRD patient in 
the sample was 21 years old and the oldest patient was 91 years old. The distribution of 
ages for the different dialysis modes is presented in Table 4.  
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Table 4  
Patients’ dialysis duration (months), GFR score and RRF score statistics. 
 
Duration  GFR  RRF 
PD HD  PD HD  PD HD 
PD only and HD only patients’ statistics 
Mean 17.62 15.66  26.33 29.46  7.99 8 
Median 13.0 13.0  24 29  8 8 
Min 0 0  2 4  4 4 
Max 104.0 116.0  55 55  12 12 
Range 104.0 116  53 51  8 8 
Sd 16.81 13.13  15.21 15.04  2.58 2.57 
PD-HD patients’ statistics 
Mean 46.12 17.81  31.1 24.88  7.56 6.37 
Median 37 12  32 25.6  7.21 6.06 
Min 0 0  1.6 1.28  3.01 2.53 
Max 121 113  83.23 66.58  14.73 12.52 
Range 121 113  81.63 65.30  11.72 9.99 
Sd 31.36 16.42  14.68 11.74  2.85 2.40 
Note. GFR is glomerular filtration rate score and RRF is residual renal function score. 
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 On average, PD-only patients in the sample spent more time in dialysis, about 
17 months on average, than HD-only patients who spent an average of 15 months in 
dialysis. PD-only patients had more varying analysis durations than HD only patients. 
The means and standard deviations of GFR and RRF scores are similar for the two 
groups with 8 and 2.6 respectively as shown in Table 4. The results also showed that PD-
HD patients on average spend more time in the PD mode than HD mode. The dialysis 
durations for PD-HD patients vary more than the dialysis durations for both PD alone and 
HD alone patients. The GFR and RRF score for PD-HD patients vary more at the PD 
stage than at the HD stage. 
The ages of the patients were further categorized into four groups: below 40 years 
old, 40 to 60 years old, 61 to 80 years’ old, and more than 80 years old. The patients were 
evenly distributed across gender by age as shown on Figure 2. Majority of the patients in 
each gender are aged between 40 years and 80 years. Most of the ESRD patients in each 
gender are aged between 61 years and 80 years. Only 0.2% of the patients were below 40 
years. 
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Figure 2. Patients' age distribution across gender. 
 Figure 3 shows the relationships in the patient’s comorbidities. The analysis 
revealed 67.74% of the patients in the sample had both diabetes with renal manifestations 
and hypertensive chronic kidney disease and 27.47% of the patients were non-diabetic 
but had hypertensive chronic kidney disease. Only 0.2% of the patients in were non-
diabetic with no CVD.  
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Figure 3. Patients’ diabetes type across cardiovascular diseases. 
The number of females who died in each age category is slightly higher than the 
number of males who died in each age category as shown in figure 4. This can be 
attributed to the fact that there were more females than males in the sample The number 
of female patients aged between 40 years and 60 years who died represent 2.28% of the 
whole sample and are slightly higher than those aged between 61 years and 80 years who 
died representing 2.16% of the whole sample. On the other hand, the difference in the 
number of male patients in these two categories who died is very small at 1.89% and 
1.87% respectively. 
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Figure 4. Patient’s state across demographic factors (gender and age). 
On the basis of co-morbidities, analysis showed that the largest percentage of 
patients who survived are those with both hypertensive chronic kidney disease and 
diabetes with renal manifestation followed by those who were non-diabetic but had 
hypertensive chronic kidney disease at 67% and 25% of the whole sample respectively. 
The percentages of patients who survived or died across diabetes type and cardiovascular 
disease are as presented in figure 5. 
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Figure 5. Patient’s state across co-morbidities (cardiovascular disease and diabetes). 
The distribution of technique failures is similar across patients’ state as shown on 
figure 6. Technical failures resulting from peritonitis constitute the highest percentage of 
the patients who died representing 4.28% followed by technical failures resulting from 
withdrawal from dialysis at 3.96%. Technique failures resulting from cerebrovascular 
disease constitute the least percentage of the whole sample with 0.06%, among the 
patients who died and 1.94% among the patients who survived. The percentage of 
technical failures resulting from acute myocardial infarction is more than twice that of 
those resulting from cerebrovascular disease among the patients who survived. In 
comparison, the percentage of technical failures resulting from acute myocardial 
infarction among the patients who died is twice the percentage of technical failures 
resulting from cerebrovascular disease.  
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Figure 6. Patients’ technical failures across state. 
Research Question One 
In this section, the effect of timing of the switch from PD to HD in maintaining 
renal function for PD-HD patients and the effect of demographic factors (age, gender) 
and co-morbidities (diabetes, CVD) on the residual renal function and survival times for 
ESRD patients are examined. The effect of switching dialysis mode from PD to HD by 
comparing the FGR scores of patients for different switching times was determined. First 
the average loss of renal function for each category of patients was visualized on a 
boxplot then the Kaplan Meier survival curves are used to visualize the survival of the 
different categories of patients. The Kaplan Meier survival curves are used to analyze 
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time taken before the occurrence of the death of a patient in the sample and the number of 
patients surviving at each time interval. To determine whether this difference in the 
survival rates is significant, the log rank tests were used. Cox-proportional hazard 
regressions were used to investigate the association between the survival rate of a patient 
and both demographic (age and gender) and co-morbidity (CVD and diabetes) factors. 
Figure 7 demonstrates the time taken by ESRD patients to switch dialysis 
modalities from PD to HD. Results demonstrates that the optimal time for switching 
dialysis modalities was 9 months with majority (8.7%) switching at this time. 
 
Figure 7. Optimal dialysis for switching dialysis modes from PD to HD 
The RRF and GFR scores for PD-HD patients in the sample was measured two 
times, 16 days before switching from PD to HD and 60 days after switching. The average 
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GFR and RRF scores are lower after switching from PD to HD compared to prior to 
switching.  
 
Figure 8. GFR score of PD-HD patients before switching to HD, across state. 
From figure 8, it is evident that PD-HD patients who died had a less varied 
distribution of GFR score than those who survived as shown by the shorter interquartile 
ranges. A t test on the two means, under the assumption of equal variances, showed that 
there was a significant difference in mean GFR across the two groups of patients. The t 
statistic was -3.473 with a p value of 0.001 at 9998 degrees of freedom. 
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Figure 9. PD-HD patients’ GFR scores after switching to HD. 
The distribution of GFR scores for PD-HD patients after switching to HD mode is 
as shown on figure 9. Once again, the patients who survived had a wider range of GFR 
scores compared to those who died. The t-test statistic, with equal variances, for 
analyzing the two means was -3.5 with a p value of 0.001 showing that the two groups of 
patients had significantly different means. A paired sample t-test comparing the GFR 
scores before and after the switch showed that the GFR means were statistically different 
with a p value of 0.000.  
The durations spent by PD-HD patients on each mode of dialysis were also 
analyzed. Figure 10 shows that the ranges for durations spent by patients who died and 
those who survived were relatively equal but the means were not, with the surviving 
patients spending, on average, less time than those who died. The statistic for the 
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independents samples test was 2.046 with a p value of 0.041 implying that the difference 
in means was significant.  
 
Figure 10. PD-HD patients’ PD durations. 
Figure 11 shows the distribution of the HD durations for PD-HD patients. Both 
the mean GFR after switching to HD for the patients who survived and those who died 
have a lot of outliers on the upper side. The figure shows that there was a group of PD-
HD patients who spent longer durations on HD relative to the mean duration spent by 
PD-HD patients on HD meaning that the distribution of HD times is skewed to the right – 
the mean HD duration is higher than the median HD duration. The statistic for an 
independent samples test, assuming unequal variances, on the means of the two groups 
was -3.451 with a p value of 0.001 implying that there is a significant difference in the 
durations spent by PD-HD patients after switching to HD between the patients who died 
and those who survived.  
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Figure 11. PD-HD dialysis durations. 
To analyze the effect of switching dialysis modalities from PD to HD on the 
improvement of GFR, a t-test was conducted. Table demonstrates the descriptive 
statistics before and after switching to HD. The results show that mean GFR before 
switching to HD was 31.098 with a standard deviation of 14.679 while the mean value of 
GFR after switching to HD was 24.879 with a standard deviation of 11.743. 
125 
 
Table 5 
Descriptive statistics 
 Mean N Std. Deviation 
Std. Error 
Mean 
 
GFR before switching to 
HD 
31.0984 10000 14.67936 .14679 
GFR after switching to HD 24.8787 10000 11.74349 .11743 
  
Table 5 depicts the results of the t-test analysis. Results show that there was 
switching dialysis modalities from PD to HD has a significant improvement on GFR. 
Switching from PD to HD improves patients GFR as shown by the changes in GFR 
values; GFR before switching to HD (M= 31.098) and GFR after switching to HD (M= 
24.879). 
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Table 6.  
Results of t-test analysis 
 Mean 
Std. 
Deviation 
Std. Error 
Mean 
t df 
Sig. (2 
tailed) 
GFR 
Before 
switching 
to HD - 
GFR 
after 
switching 
to HD 
6.21967 2.93587 .02936 211.851 9999 0.000 
 
To analyze the effect of switching times on the loss of renal function, the 
switching times were grouped into four strata and the average loss of renal function per 
day was determined by calculating the average decrease of GFR score for each HD-PD 
patient in each category. The average decreases are shown on figure 12. The center 
horizontal line on each boxplot represents the median, the dots represent the mean 
decrease in GFR score per day for the category and the label is its value. The mean 
decrease in GFR score decreases with increase in age. PD-HD patients who took at least 
73 months before switching to HD have the highest interquartile range in their average 
decrease in GFR scores.  
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Figure 12. Average decrease in GFR score per day for different switching times. 
Based on gender, male patients who took at most 24 months before switching to 
HD and those who took at least 73 months before switching had a higher loss of residual 
renal function per day than the females as shown on figure 13. On the other hand, male 
patients who switched dialysis mode between 25 and 72 months had a lower loss or 
residual renal function per day than the females.  
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Figure 13. Average decrease in GFR across gender. 
Examining the survival rates of PD-HD patients across gender, the analysis 
showed that there is no significant difference between male and female patients’ survival 
rates as shown in figure 14 below. The gender variable had only two levels; male and 
female. The p-value for the log rank test is 0.145 which is greater than the significance 
level of 0.05. This implies that the survival rates do not vary significantly across gender. 
The coefficient for the females in the cox-proportional hazard regression using males as 
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the base level is – 0.148 with a p-value of 0.0335 which is less than 0.05 implying that 
females are at a significantly lower hazard of dying from ESRD compared to males. 
 
 
Figure 14. PD-HD patients’ survival rates by gender. 
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Figure 15. Average decrease in GFR across age. 
Examining the loss of renal function across age reveals that patients who are over 
80 years old and have taken more than 24 months before switching to HD had the highest 
loss of renal function depicted by a daily decrease of GFR score of more than 0.1 
mL/min/1.73 m2 as shown on figure 15. On the other hand, patients who are less than 40 
years old and took between 25 months and 48 months before switching to HD had the 
lowest daily reduction in GFR score of 0.8 mL/min/1.73 m2.  
Across age, there were four levels; patients aged below 40 years, those aged 
between 40 years and 60 years, those aged between 60 years and 80 years ,and those aged 
over 80 years as shown in figure 16. On the basis of survival rates, patients aged between 
40 and 60 years and those aged between 60 and 80 years had a higher survival rate than 
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those patients aged below 40 years or aged over 80 years. The p-value for the log rank 
test is 0.0001 indicating a significant difference in survival rates across age categories. 
Using patients aged below 40 years as the base level, the cox proportional hazard 
regression revealed that patients aged between 40 and 60 years and those aged between 
61 and 80 years are at a higher hazard than the base level with regression coefficients 
0.71 and 0.19 respectively and p values 0.0254 and 0.5494 respectively. According to the 
p values, the coefficient for those aged between 40 and 60 year is significant. In 
comparisons, patients aged over 80 years are at an insignificant lower hazard relative to 
the base level with a regression coefficient of –0.6079 and a p-value of 0.099. 
 
Figure 16. PD-HD patients’ survival rates by age. 
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Research Question Two 
The average loss of renal function was compared for cardiovascular disease 
measured by the decrease in GFR score. Patients without hypertensive chronic kidney 
disease had a higher daily loss of renal function compared to patients without 
hypertensive chronic kidney disease as shown on figure 16. This can be explained be the 
fact that though the percentage of ESRD patients in the sample without a cardiovascular 
disease was only 4%, most of these patients were diabetic. The percentage of diabetic 
patients without a cardiovascular disease in the sample was 96% (67.74% + 0.79% + 
27.47%). Thus, the higher loss of renal function among patients without hypertensive 
chronic kidney disease can be attributed to diabetes. 
 
Figure 17. Average decrease in GFR across cardiovascular disease. 
Patient’s CVD had two levels. The first level is patients without hypertensive 
chronic kidney disease (No HTN) and the second level is patients without hypertensive 
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chronic kidney disease (HTN). The sections of the curve crossed with lines are the 
censored values (patients who were still alive by the end of the study). With regard to 
survival rates, patients with hypertensive chronic kidney disease had worse survival rates 
than those without. The survival rate is indicated in figure 17. The p-value for the log 
rank test is 0.695 indicating an insignificant difference in survival rates across 
cardiovascular disease. The coefficient for the patients with hypertensive chronic kidney 
disease in the cox-proportional hazard regression was determined using patients without 
hypertensive chronic kidney disease as the base level. The coefficient obtained was 
1.3164 with a p-value < 0.0001, which is less than 0.05, implying that patients with 
hypertensive chronic kidney disease are at a significantly higher hazard compared to 
those without. 
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Figure 18. PD-HD patients’ survival rates by cardiovascular disease. 
 On the basis of diabetes type, there were three levels of diabetes. The first 
represented patients without diabetes. The second one is patients with diabetes with 
chronic kidney disease and the third one is patients with diabetes with renal 
manifestations. Investigating the average loss of renal function across diabetes type 
revealed that patients with diabetes with chronic kidney disease had the highest daily loss 
of residual renal function followed by those with diabetes with renal manifestations as 
shown on figure 18. Non-diabetic patients had the least loss of renal function per day. All 
the diabetic patients in the sample took at most 72 months in PD before switching to HD.  
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Figure 19. Average decrease in GFR across diabetes type. 
The survival rates of PD-HD patients without diabetes were lower than the 
survival rates of those with diabetes. The survival curves for patients with either diabetes 
with renal manifestation or diabetes mellitus with chronic kidney disease are close to 
each other as shown in figure 19. This implies that the survival rate for the two types of 
diabetes is similar. The difference between survival rates for diabetic patients and non-
diabetic patients was tested using the log-rank test. The p-value for the log-rank test is 
0.107 which is less than the significance value (5%) implying that survival rates 
significantly vary across diabetes type. For the cox proportional hazard, non-diabetic 
patients were specified as the base level. The regression coefficients for the patients with 
diabetes with renal manifestation and those with chronic kidney disease are – 1.783 and – 
0.155 implying that, relative to the non-diabetic patients, the hazard decreases if a patient 
is diabetic. This decrease for patients with diabetes with renal manifestation is significant 
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with p value < 0.000 while that one for patients with diabetes with chronic kidney disease 
is insignificant with a p value of 0.978. 
 
Figure 20. PD-HD patients’ survival rates by diabetes type. 
Research Question Three 
Cochran Mantel Haenszel test was used to determine whether the effects of 
demographic factors and co-morbidity factors on optimal switching times for PD-HD 
ESRD patients are independent. The Cochran Mantel Haenszel is the test of conditional 
dependence with a null hypothesis that two variables are independent over a third factor. 
The test was used to determine whether co-morbidities are independent over 
demographic factors.  
Effect of co-morbidities on GFR across gender. The effect of diabetes and 
cardiovascular diseases on GFR was tested to determine whether it was similar across 
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gender. The three way contingency table 7 summarizes the total GFR across diabetes and 
cardiovascular diseases for gender. Applying Cochran Mantel Haenszel test on table 5; 
yields a p-value of 0.0062 which is less than α-level of 0.05 implying that the effect of 
co-morbidities on GFR varies across gender. 
Table 7  
Patients’ medical conditions(total GFR) across gender. 
Diabetes type 
Cardiovascular 
disease 
Gender 
Male Female 
Diabetes with renal 
manifestation 
HTN 1.61 2.39 
 No HTN 6.21 8.74 
Diabetes with chronic kidney 
disease 
HTN 0.14 0.09 
 No HTN 0.46 0.39 
No diabetes HTN 0.06 0.11 
 No HTN 33.8 45.99 
 
Effect of co-morbidities on GFR across age. The total GFR across diabetes and 
CVD over age tested is presented in table 8. The p-value for the Cochran Mantel 
Haenszel test on the contingency table yielded a p-value of 0.0002 which is less than α-
level meaning that the effect of co-morbidities on GFR varies across age. 
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Table 8  
Patients’ medical conditions (total GFR) across age. 
Diabetes type 
Cardiovascular 
disease 
Age category in years 
< 39 40-60 61-80 > 80 
Diabetes with renal 
manifestation 
HTN 0 0.42 2.21 0.69 
 No HTN 0 1.86 8.75 2.64 
Diabetes with chronic 
kidney disease 
HTN 0 0.02 0.1 0.06 
 No HTN 0 0.09 0.47 0.19 
No diabetes HTN 0 0.04 0.09 0.06 
 No HTN 0.77 38.90 41.4 1.22 
 
Effect of co-morbidities over optimal dialysis switching times across gender. 
The co-morbidities over optimal dialysis times for PD-HD patients across gender are 
presented in table 9 below. Applying Cochran Mantel Haenszel test on the table yields a 
p-value of 0.029. This implied that the effect of co-morbidities on optimal dialysis times 
vary across gender. 
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Table 9 
Summary of co-morbidities over optimal dialysis times for PD-HD patients. 
Diabetes type 
Cardiovascular 
disease 
Gender 
Male Female 
Diabetes with renal manifestation HTN 2.30 3.58 
 No HTN 9.57 14.77 
Diabetes with chronic kidney 
disease 
HTN 0.22 0.12 
 No HTN 0.67 0.70 
No diabetes HTN 0.06 0.14 
 No HTN 28.36 39.50 
 
Effect of co-morbidities over optimal dialysis switching times across age. The 
co-morbidities over optimal dialysis times for PD-HD patients across age are presented in 
table 10 below. The p-value for the Cochran Mantel Haenszel test on this contingency 
table yielded a p-value of 0.0001 which is less than our significance level meaning that 
the effect of co-morbidities on optimal dialysis times varies across age. This indicates 
that the relationship between co-morbidity factors and both GFR and optimal dialysis 
times varies across age. 
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Table 10 
PD-HD patients’ dialysis times across age. 
 
Moreover, multivariate cox proportional regressions revealed the following 
associations between the survival of a patient and combinations of both demographic 
factors (age and gender) and co-morbidities (cardiovascular disease and diabetes type). 
Three regressions were done. The first one was between the patients’ survival and co-
morbidities (cardiovascular disease and diabetes type), the second one between patient’s 
survival and demographic factors (age and gender), and the third one between patient’s 
survival and both the co-morbidities and demographic factors (cardiovascular disease, 
diabetes type, age and gender). The cox proportional results are shown on table 11.  
Diabetes type 
Cardiovascular 
disease 
Age category in years 
< 39 40-60 61-80 > 80 
Diabetes with renal 
manifestation 
HTN 0 0.75 3.75 1.38 
 No HTN 0 3.70 15.68 4.96 
Diabetes with chronic 
kidney disease 
HTN 0 0.03 0.15 0.16 
 No HTN 0 0.11 0.81 0.45 
No diabetes HTN 0 0.04 0.15 0.02 
 No HTN 1.68 28.24 35.47 2.47 
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Table 11 
Cox proportional regression results. 
Factor Coefficient Hazard Ratio P value 
Co-morbidities (diabetes type and cardiovascular disease) 
Hypertensive chronic kidney 
disease  
-0.0468 0.654 0.878 
Diabetes with renal 
manifestations 
-1.791 0.1667 < 0.0001 
Diabetes with chronic 
kidney disease. 
-15.53 <0.0001 0.978 
 
Demographic factors (age and gender) 
40 – 60 years 0.7314 2.0779 0.0227 
61 – 80 years 0.2091 1.2325 0.5144 
80 - years -0.588 0.5549 0.1102 
Female -0.1359 0.8729 0.0513 
    
Co-morbidities and Demographic factors 
Hypertensive chronic kidney 
disease  
-0.0715 0.931 0.8146 
Diabetes with renal 
manifestations 
-1.697 0.1833 < 0.0001 
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Diabetes with chronic 
kidney disease. 
15.39 <0.0001 0.9778 
40 – 60 0.9511 2.589 0.0031 
61 – 80 0.6081 1.837 0.0587 
80 -  0.2894 1.336 0.4357 
Female -0.1393 0.8699 0.0458 
 
Since all the four independent variables for these cox proportional regressions are 
categorical, one level of each factor was used as the base level. For diabetes type the 
levels were no diabetes (base level), diabetes with renal manifestations, and diabetes with 
chronic kidney disease. The levels for cardiovascular disease were hypertensive chronic 
kidney disease and no hypertensive chronic kidney disease (base level). For gender, the 
levels were male (base level) and female while the levels for age were less than 40 years 
(base level), less than 61 years (40-60), less than 81 years (61-80), and greater than 80 
years. 
The base level is used as the reference while interpreting the cox proportional 
coefficients. For co-morbidities, patients with no diabetes were used as the base category 
for diabetes type and those with no cardiovascular disease were used as the base category 
for cardiovascular disease. For demographic factors, patients aged less than 40 years were 
used as the base category for age and male patients were used as the base category for 
gender.  
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In table 11, a positive cox proportional regression coefficient implies that the risk 
of death is higher while a negative coefficient implies the risk of death is lower. The 
hazard ratio is calculated as the exponent of the regression coefficient. It shows the factor 
by which each factor reduces or increases the hazard relative to the base 
category/categories. P values less than 0.05 indicate significant regression coefficients.  
Including both CVD type and diabetes type in the cox regression model showed 
that relative to a patient who is not suffering from either diabetes or a CVD, the risk of 
death is significantly lower if an ESRD patient is suffering from diabetes with renal 
manifestations with regression coefficients – 1.791 and p value< 0.0001 as shown in table 
9. Similarly, including both age and gender in the regression model showed that the risk 
of death is significantly higher if a patient is aged between 40 and 60 years relative to a 
male patient who is aged below 40 years. The risk of death is significantly lower, 
however, if the patient is female with a p value of 0.0513.  
Including both demographic factors (age and gender) and co-morbidities (CVD 
and diabetes) in the cox proportional regression model showed that relative to a male 
patient aged below 40 years and not suffering from either a cardiovascular disease or 
diabetes, the risk of death significantly decreases if the patient is either female or is 
suffering from diabetes with renal manifestations with p values 0.0458 and <0.0001 
respectively. By comparison, this risk of death significantly increases if the patient is 
aged between 40 and 60 years with a p value of 0.0031.In conclusion, the effect of co-
morbidities on both GFR and optimal dialysis switching time vary across both age and 
gender. Similarly the effect of demographic factors on GFR and switching times will vary 
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across co-morbidities. Thus the optimal dialysis switching time is dependent on the 
health condition, the age, and the gender of the patient.  
Summary 
The study investigated whether the timing of the switch from PD to HD is more 
effective on maintaining renal function than PD or HD alone, including demographic 
factors (age, gender) and co-morbidities (diabetes, CVD) significantly improve renal 
function and survival times for ESRD patients compared to either PD or HD alone. The 
study also sought to understand the optimal dialysis time taken by patients switching 
from PD to HD due to various reasons such as technique failure or death. The study also 
assessed the effect of demographic characteristics and co-morbidities on the optimal 
dialysis for switching. Results from Kaplan Meir estimate indicate that majority (92%) 
survived in between the study period. Results from log-rank also show that the survival 
rates for patients with and without diabetes are varying whereby Kaplan Meir estimates 
indicated that the survival rates of non-diabetic after switching were higher than those 
with diabetes. Patients between age 40 and 60 years had the best survival rates as well as 
patients with cardiovascular diseases after switching dialysis modes. Moreover, the 
mantel haenszel test focused on examining whether demographic factors or co-morbidity 
factors are independent over ESRD patients’ survival times. The results showed that the 
effect of co-morbidities on patients GFR varies across gender and age. Similar results 
were obtained on the effect of co-morbidities on the optimal time for switching varying 
across age and gender. Cox proportional hazard regressions showed that patients with 
CVD have less survival times compared to patients with cardiovascular diseases whereas 
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patients between ages 40 and 80 years have higher hazards of dying as compared to 
patients below 40 years and above 80 years.  
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The section presents the discussion of findings in relation to the research 
questions while simultaneously explaining the theoretical perspective. The research study 
focused on examining whether the timing of the switch from PD to HD is more effective 
in maintaining renal function than PD or HD alone considering the demographic factors 
(age and gender) as well as the comorbidities (diabetes and CVD). In addition, I 
examined whether the timing of the switch from PD to HD significantly improve renal 
function and survival times for ESRD patients compared to either PD or HD alone. 
Several studies have been conducted on examining the effect of PD, HD, or switching 
from PD to HD on maintaining renal function but the studies employed a small sample 
size. However, my study aimed at filling the gap by employing a large sample size of 
records of patients from a national registry database of over 128,000 patients undergoing 
dialysis at National Dialysis Center. Moreover, the study focused on establishing the 
impact of optimal dialysis time for switching from PD to HD on ESRD patients residual 
renal function and survival times. The study focused on whether there is an improvement 
when controlling for demographics and comorbidities. This chapter discusses the results 
in relation to the literature review whereby the discussion is aligned with the research 
questions of the study. The first section highlights summary of study findings, the second 
section details the study objectives while the last section presents the conclusion and 
recommendations for future work. 
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Summary of Findings 
The study examined whether switching dialysis modes from PD to HD improves 
patients’ residual renal function and survival rates while controlling for demographics 
and comorbidities. A national database consisting of 128,000 medical records of patients 
undergoing dialysis was utilized. Descriptive findings showed that there were more 
female patients (57%) than male patients (43%) across the three dialysis modes PD, HD, 
and PD to HD. The sample chosen consisted more of whites (70.87%) and more than 
two-thirds of the patients were university graduates. Among the three dialysis modes, the 
majority (91.58%) of the participants examined in the study are alive. Moreover, the 
mean age of patients engaging in dialysis was 62 years whereby the minimum age was 21 
years while the maximum age was 91 years. In addition, the larger percentage of the 
ESRD patients had diabetes as well as CVD (hypertension).  
Results illustrated that the optimal duration for switching dialysis modalities was 
9 months. The major cause for switching was peritonitis which was a result of technique 
failure. The findings for the first research question indicated that the optimal dialysis for 
switching had an impact on the survival rates and the residual renal functions for patients 
with end stage renal diseases. The results demonstrated that there was significant 
difference between dead and live patients for patients on PD and after switching to HD. It 
was discovered that patients who had died hads had spent more time on PD than patients 
who were still living. Additionally, patients who were still alive spent more time on HD 
than those how had passed away. Specifically, the findings show that of the majority of 
patients switching from PD to HD that survived were patients without diabetes as 
148 
 
compared to those diagnosed with diabetes. The log-rank test confirmed the significant 
difference. Log-rank values indicated that patient’s survival rates varied significantly 
across patients with comorbidities whereby patients with cardiovascular diseases were 
observed to have better survival times than patients without cardiovascular diseases.  
In addition, the findings showed that patient’s survival does not vary significantly 
across gender but varies significantly across age whereby patients aged between 40 and 
50 years had best survival rates. Moreover, the effect of comorbidities on patient’s GFR 
varied significantly across both the age and gender. The results demonstrated that 
switching from PD to HD had significant effect on patient’s GFR. A t test conducted 
revealed that significant difference on GFR was observed for patients before and after 
switching to HD. The GFR for patients decreased after switching to HD depicting 
effectiveness of switching dialysis modes. The findings answered the second research 
question which indicated that the patient’s comorbidities had a significant impact on the 
optimal dialysis time for switching when controlling for gender. The effect of 
comorbidities on optimal dialysis time for switching across gender was found to be 
significant, as indicated by the Cochran Mantel Haenszel test. The findings indicated that 
the optimal switching times for patients without diabetes and hypertension were higher 
across gender compared to patients with diabetes and CVD. Similarly, effects of 
comorbidities over optimal dialysis switching time varied significantly across age. 
Female patients and non-diabetic patients were found to have higher survival rates.  
The third research question focused on establishing the effect of demographic 
characteristics on patients’ optimal dialysis time for switching when controlling for the 
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patient’s comorbidities. The findings indicated that male respondents were associated 
with shorter durations for switching. In addition, gender had an effect on switching times 
when controlling for the GFR and survival rates. Male patients taking different durations 
for switching were observed to have lower residual renal function compared to female 
counterparts. Moreover, results showed that there was no significant gender difference in 
patients’ survival rates. In addition, patients aged 40-60 years had better optimal dialysis 
switching modes, improved survival rates, as well as improved GFRs. Patients aged 40 to 
80 years had better hazards of surviving compared to patients over 80 years and below 40 
years. 
Limitations of the Study 
Limitations are considered as the occurrences that arise in the study which are 
beyond the researcher’s control (Simon & Goes, 2013). Limitations affect the study 
outcomes as well as results and every study is bound to have study limitations (Simon & 
Goes, 2013). The limitation of this study is the use of secondary data. Secondary data is 
associated with possible errors and biasness (Tasić & Feruh, 2012). Possible errors of 
secondary data arise from invalidation of data, the presence of the sampling and non-
sampling errors, as well as reduced data reliability (Tasić & Feruh, 2012). The secondary 
data may be tampered with due to attitudes of the person organizing the collection of 
data. In addition, organizations conducting the data collection may exercise carelessness 
or confusion in the recording of the data which contributes to invalid results (Tasić & 
Feruh, 2012). As for the research study, limitations of the secondary data is the similarity 
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of descriptive findings for the three dialysis modes; PD, HD, and PD to HD. This may 
have been attributed with errors in the data collection process.  
Recommendations 
The research findings found varied results on the effect of optimal dialysis time 
for switching among ESRD patients. The factors contributing to technique failure were 
distinct. However, various studies also indicated that the reasons for technique failure 
among the PD have not yet been researched (Chaudhary, 2011). The study focused on 
contributing to theory by examining the reasons contributing to technique failure among 
ERSD patients initiating dialysis by use of PD. In addition, the study found out that 
demographic characteristics of ESRD patients influenced patient survival rate and 
improved renal replacement therapy. However, the study did not provide the reasons for 
the existence of gender differences in improving renal replacement therapy and survival 
times. This provides a basis for conducting further studies to examine the reasons female 
ESRD patients have better survival outcomes as compared to the male ESRD patients. 
Implications 
Implications of Theory  
Research Question 1. The research question focused on identifying the optimal 
dialysis time for switching from PD to HD for ESRD Patients when controlling for 
demographic and comorbidity patient factors. The findings indicated that the optimal 
duration for switching from PD to HD among ESRD patients was 9 months. The results 
differ with the findings by Jaar (2009) who found that 70% of ESRD patients initiating 
dialysis with PD switched to HD within the first two years. The reason for switching was 
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due to dialysis technique failure which is caused by different factors (Chaudhary, 2011). 
In order for the patients to switch from PD to HD or the technique failure to occur, 
patients must have engaged dialysis under the PD mode for 6 months while other patients 
consider swapping to HD permanently (Descœudres et al., 2008). The study results 
indicate that the major technique failure was PD.  
However, a study by Betty et al. (2013) indicated that patients switch dialysis 
modes within the first year or second year after initiating dialysis. The main reasons for 
switching from PD to HD were increased costs of dialysis provision, hospitalization, as 
well as medication (Betty et al., 2013). In addition, the technique failure of the PD still 
remains high as observed in studies by Matthew et al. (n.d) and Hsieh et al. (2017); thus, 
research as towhy the technique failure in PD is high is still needed. The study findings 
are constituent with major research studies conducted which indicated that PD is the 
major cause of technique failure (Chaudhary, 2011; Workeneh, Guffey, Minard, & Mitch, 
2015). Though the main reason of switching from PD to HD is PD, a majority of 
participants may experience inadequate dialysis, the presence of burnout as well as 
persistent exit site infection (Workeneh et al., 2015).  
The technique failure was observed to prevail within the first one or two years 
after initiating dialysis under PD. The findings also indicated that withdrawal from 
dialysis was a major cause of technique failure. This aligns with the findings by 
Weinhandl et al. (2016) who found that the reason for switching from PD to HD was 
withdrawal from the dialysis. In addition, other causes of technique failure that emerged 
observed in my findings are acute myocardial infarction and cerebrovascular disease. 
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Quinn et al. (2010) indicated that technique failure is caused by individual complications 
of the dialysis modality which results to death. It is thus, essential to detect factors 
contributing to technique failure early enough by monitoring infection rates to improve 
survival (Bechade et al., 2014).  
The research hypothesis focused on determining whether the timing of the switch 
from PD to HD impacts renal function and survival times. The findings indicated that 
patients spent most of their dialysis times at PD as compared to the patients that engaged 
in HD. A larger number of patients under PD before switching to HD lived and took an 
average duration of 45 months compared to patients that died that took an average 
duration of 48 months. Moreover, there were a great number of patients surviving after 
switching to HD whereby those surviving took a longer period in HD compared to those 
that died. The results are consistent with the study by Sinnakirouchenan and Holley 
(2011) who indicated that the survival advantage of patients under PD continues for 1.5 
to 2 years. The risk of death of patients over time becomes greater or equal to the in-
center HD. Similar results were recorded by Pajek et al. (2014) who observed the risk of 
median time to death under PD was 2.73 years before switching to HD. Long-term 
survival rates are recorded in PD and at risk death of patients starting dialysis at PD 
becomes lowered (Chen, Mehrotra, & Kalantar-Zadeh, 2014). Patient’s performance is 
steady at PD for the first two years where patients decide to switch to HD afterwards 
(Pike et al., 2017). 
In addition, most of the patients that were included in the sample survived. The 
patients without diabetes survived longer than the patients with diabetes. Similarly, 
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patients with CVD were observed to have longer survival rates than patients without 
cardiovascular. The findings are inconsistent with the findings of a study conducted by 
Liu et al., (2013), which indicated that the survival rates for the patients with CVD under 
PD and HD have not yet been established. The long optimal dialysis for switching was 
observed due to the fact that young adults with diabetes and CVD perform better PD than 
in HD (Yang et al., 2015). The determination of the survival rates for patients under PD 
or in HD have been challenging due to the fluctuation of methodologies used in various 
studies. Results demonstrated that significant difference on GFR was observed for 
patients before and after switching to HD. The GFR for patients decreased after switching 
to HD depicting effectiveness of switching dialysis modes. Results were consistent with 
the study by Ghaffari et al. (2013) that demonstrated that initial dialysis through the use 
of PD is associated with management and improvement of residual renal function where 
the management residual renal function improves patient’s survival rates. Similarly, 
Chaudhary et al. (2011) and Dalal et al. (2011) indicated that starting dialysis modality 
using PD increases preservation of RRF when one has switched to HD thus, supporting 
the switching technique. 
Research Question 2. The research question focused on the impact of 
comorbidities on the optimal dialysis time for switching from PD to HD for ESRD 
Patients when controlling for demographic patient factors. The research question also 
focused on assessing whether the presence of comorbidities for switching patients 
significantly affects the residual renal function when controlling for demographics. The 
findings indicated that there were varying results of patient’s cardiovascular diseases and 
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diabetes on residual GFR across the gender. The GFR for patients without diabetes and 
without hypertension was higher for females compared that of males. The findings 
conform to the findings of a study by Cadnapaphornchai and Teitelbaum (2014) who 
indicated that ESRD patient’s residual renal function is maintained by controlling co-
morbidities. However, findings obtained in a study conducted by Tian et al., (2016) 
established that the presence of cardiovascular diseases among hypertension as well 
increase in comorbidities such as diabetes contributes to volume overload and thus 
reduced renal replacement therapy.  
The patients with cardiovascular diseases have worse results and outcomes in 
relation to survival rates as compared to ESRD patients without diabetes and 
cardiovascular diseases (Zyga & Kolovos, 2013). The demographic characteristics of 
ESRD patients significantly contribute to the reduction in residual renal replacement 
therapy (Mathew et al., 2016). The findings indicated that the GFR for ESRD patients 
without diabetes and hypertension varied significantly across the age group of patients. 
Specifically, the GFR for ESRD patients without hypertension and diabetes was observed 
to be high for patients within the age group of 40 to 60 years. The findings are consistent 
with results of a study by Tian et al. (2016) who observed that older patients are more 
likely to have problems with residual renal functions due to increased volume overload. 
Studies by Weinhandl et al. (2010) and Shen et al. (2012) indicated that younger patients 
have better survival rates under PD than older adults. The results of the study indicated 
that the effect of co-morbidities on optimal dialysis times for switching varies 
significantly across gender.  
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The results depicted that for the patients without diabetes and without 
hypertension, the optimal dialysis times was high in females as compared to males. The 
findings are consistent with the results of a study by Hecking et al. (2014) who indicated 
patients with co-morbidities are more likely to shift from PD to HD. Moreover, the great 
number of switching is expected to rise among male than females as the males are prone 
to coronary diseases as well as diabetes. Similar results were observed for the age group 
where the optimal dialysis times for patients between 40 to 60 years and 60 to 80 years 
was observed to be high . Studies conducted indicate that there is improved quality of life 
for younger adults in PD than on HD (Noshad et al., 2009; Stanley, 2010). In addition, a 
timely transfer from PD to HD is expected to raise survival rates and decrease patient’s 
mortality rates especially for the patients with cardiovascular diseases and diabetic 
patients. The elderly patients are prone to contract these diseases which force them to 
shift to HD as it is more manageable for the elderly patients (Stanley, 2009). However, a 
study conducted by Jaar et al. (2009) did not find any significant difference for the 
patients switching from PD to HD across the age, gender, diabetes, and cardiovascular 
diseases. 
Research Question 3. The study aimed to establish the impact of demographic 
characteristics on optimal dialysis time for switching when controlling for co-morbidities. 
The results showed that patients’ age and gender significantly contribute to the variation 
of optimal dialysis time for switching. More importantly, males are considered to switch 
earlier than females. The males GFRs and RRFs were significantly observed to be lower 
than the females on varying durations for switching. Weinhandl et al. (2010) found a 
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positive contribution of demographic factors such as age and gender on the choice of 
dialysis technique, switching mode and the survival rates. In addition, age was considered 
to vary the durations for switching whereby patients having shorter duration times were 
aged between 40 and 80 years. Younger patients are associated to initiate dialysis with 
PD as it improves their outcomes compared to the elderly who have better patient 
outcomes on HD (Weinhandl et al., 2010; Yeates et al. (2012). The presence of co-
morbidities such as diabetes affects the adoption of dialysis modes according to age. 
Thus, the elderly are considered to have longer durations for switching when initiating 
dialysis on PD.  
The findings indicate that for patients in the same durations of switching, the 
older adults (80 years or more) were considered to have the highest loss of RRFs as 
depicted by their GFR compared to patients aged 40 years and below. It is important for 
the age to be adjusted to 65 years for ESRD patients planning to initiate dialysis on PD 
and then switching to HD as it associated with improved outcomes among patients. Age 
as a risk factor to survival rates is observed to affect the time of switching. The elderly 
patients are associated with high loss of renal replacement therapy due to the presence of 
diseases such as diabetes and cardiovascular disease. The majority of patients starting 
renal replacement therapy in the USA are patients aged 75 years or more (Franco & 
Fernandes, 2013; Seckinger et al., 2016). In addition, patients aged between 40 and 80 
years have better survival rates compared to patients aged 80 years or more or below 40 
years. The findings showed that patient survival for the elderly was better than that of the 
young population which is are inconsistent with major studies (de Melo et al., 2016). 
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However, patients over 80 years were observed to have lower hazards to survival. The 
metabolic functions, as well as psychological functions of body organs, decrease with 
increase in age. The elderly has lower life expectancy and lack exercises which contribute 
to a rise of chronic diseases (Segall et al., 2015; Seckinger et al., 2016). Moreover, 
patients at the age of 60 years with no diabetes have better survival rates than patients at 
the age 60 years with diabetes (Yamaga et al., 2012). 
Implications for Practice 
The research study revealed various results to be useful in managing the end stage 
renal disease. The results indicated that patients on minimum spent 37 months to switch 
from PD to HD. It is expected that timely switching from PD to HD would help improve 
the survival rates and mortality rates of the ESRD patients (Stanley, 2010; Jaar et al., 
2010). The initiation of dialysis by use of PD is considered to be effective than initiating 
dialysis on HD. Specifically, the younger population is advantaged to begin dialysis with 
PD before switching as it associated with improved patients survival outcomes (Stanley, 
2010; Workeneh et al., 2015; Erez et al., 2016; Pike et al., 2017) and improved residual 
renal function (Dalal et al., 2011; Chaudhary et al., 2011; Ghaffari et al., 2013). The 
ESRD patients aged 40 years and above initiating dialysis by use of PD have better 
survival outcomes in the initial stages but the condition worsens as the time for switching 
is delayed (Wang at al., 2017). The study results showed that the most risk factor for 
technique failure among ESRD patients was peritonitis. Several other studies have shown 
that peritonitis is the major cause for technique failure (Chaudhary, 2011; Workeneh et 
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al., 2015; Pajek et al., 2014; Wang et al., 2017). The patients undergoing dialysis by use 
of PD are required to maintain extra care to minimize infections. 
 In addition, healthcare professionals and medical facilities are required to raise 
the awareness of patients on proper use of dialysis tools to minimize incidences of 
peritonitis. In addition, the majority of ESRD patients spent most of their time at PD 
dialysis as compared to HD dialysis. The use of dialysis modality under PD is associated 
with lower cost of therapy and flexibility schedule (Chui et al., 2013; Ghaffari et al., 
2013; Tataradze et al., 2016). In order to improve patient outcomes, the patients should 
be advised to start dialysis under PD in order to enhance the freedom from frequent 
hospital visits and have less interference with everyday life (Erez et al., 2016). The 
findings indicated that patients without diabetes have longer survival times after 
switching from PD to HD. Moreover, patients with diabetes and cardiovascular diseases 
perform better under PD than in HD (Stanley, 2010; Erez et al., 2016). Thus patients with 
diabetes and cardiovascular diseases should switch dialysis modality in order to increase 
survival.  
The rise in patients BMI contributing to co-morbidities makes the patients switch 
dialysis modality in order to deal with mortality rates (Jaar et al., 2009). The GFR and the 
renal replacement therapy for the elderly continue to worsen due to the increased co-
morbidity risk factors. Moreover, due to the increased risk factors of coronary diseases 
among male patients, the switching is likely to increase (Hecking et al., 2014). Thus, 
males should be challenged to live healthy lifestyles to avoid co-morbid diseases. In 
addition, switching to hemodialysis is associated with several challenges such as 
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hindrance of mobility, minimal socializing, increased costs, stress, and poor adherence to 
treatment (Nasiri et al., 2013; Ahmad & Al Nazly, 2014). It is, therefore, important for 
patients to initiate dialysis for a longer period by use of PD before switching in order to 
improve their survival rates.  
Conclusion 
The study examined whether the timing of the switch from PD to HD is more 
effective in maintaining renal function than PD or HD alone considering the demographic 
factors (age and gender) as the co-morbidities (diabetes and cardiovascular diseases). The 
study focused on examining whether switching from PD to HD improves the residual 
renal function or survival rates other than HD or PD alone. Patients’ optimal dialysis time 
was established to be 9 months which is necessary for patients with cardiovascular 
periods. Patients with end stage renal disease are expected to spend more time in 
Peritoneal Dialysis due to challenges of mobility, adhering to dialysis as well as spending 
more time in the hospital. However, several studies indicated that the survival rates of 
ESRD patients associated with peritoneal dialysis are very low, thus advocating for 
timely transfer to HD. Moreover, there lacks empirical findings as to why there is 
increased technique failure among ESRD patients using peritoneal dialysis. 
 In addition, the study indicated that technique failure was the major reason for 
switching modalities. The main risk factor for technique failure was identified to be 
peritonitis. Several studies have shown that peritonitis arises due to infections of the 
machines and equipment. Moreover, technique failure arose due to withdrawal from 
dialysis and presence of co-morbidity complications. Patients spent more time in 
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peritoneal dialysis as compared to hemodialysis. The younger patients with 
cardiovascular diseases and diabetes are observed to spend more time in peritoneal 
dialysis as it associated with improved patient outcomes. In addition, the determination of 
survival rates in peritoneal dialysis and hemodialysis is challenging due to the existing 
fluctuations in various research methodologies.  
The impact of co-morbidities on the residual renal function varied significantly 
across age and gender. The GFR for the patients without diabetes and hypertension was 
higher in females as compared to that of men. Men are observed to have high incidences 
of co-morbidities which influence changes in their GFR compared to females. The GFR 
for patients without diabetes and hypertension was considered high for patients aged 40 
to 60 years. The younger patients have better survival rates than the older population 
since the older patients are more likely to have problems with residual renal functions due 
to increased volume overload. In addition, female patients without diabetes and 
hypertension have a high optimal time for switching. 
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